Skip to main content

Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
In Person Only
In Person Only
Location: Hilton San Diego Bayfront
Location: Hilton San Diego Bayfront

Abstracts

Abstracts

  • Sunday, October 1, 2023
  • 8:00 AM – 8:07 AM PT
    100 - Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk DCIS after Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Base
    Location: Room 6 B

    Presenter: Frank Vicini, MD, FASTRO – GenesisCare

  • 8:10 AM – 8:17 AM PT
    101 - Long Term Outcomes of Radiation (RT)-Monotherapy vs. Combined RT + Endocrine Therapy (RT+ET) in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older after Breast-Conserving Surgery (BCS)
    Location: Room 6 B

    Presenter: Astrid Morris, MD, MS – Tumor Institute Radiation Oncology Group

  • 8:20 AM – 8:27 AM PT
    102 - Physician and Patient-Reported Outcomes of a Phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the Whole Breast after Breast-Conserving Surgery
    Location: Room 6 B

    Presenter: Brady Laughlin, MD – Mayo Clinic Arizona

  • 8:30 AM – 8:37 AM PT
    103 - Impact of Neoadjuvant Concurrent Chemoradiation (NACCRT) on Operability and Survival in Locally Advanced Inoperable Breast Cancer
    Location: Room 6 B

    Presenter: Priya Iyer, MD, RT, MBBS – Cancer Institute (WIA)

  • 8:40 AM – 8:47 AM PT
    104 - Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in India
    Location: Room 6 B

    Presenter: Rajiv Sarin, MD, FRCR – Tata Memorial Centre

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 6 B

    Discussant: Jean Wright, MD, FASTRO – Johns Hopkins University

  • 8:00 AM – 8:07 AM PT
    110 - STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung Injury
    Location: Room 32

    Presenter: Shisuo Du, MD, PhD – Zhongshan Hospital Fudan University

  • 8:10 AM – 8:17 AM PT
    111 - Early and noninvasive PET imaging of radiation-induced lung injury by targeting CXCR4
    Location: Room 32

    Presenter: Jie Liu, MD – Shandong Anti-Cancer Association

  • 8:20 AM – 8:27 AM PT
    112 - Subacute Cutaneous Toxicity with Single-Fraction Electron FLASH RT in Yorkshire Swine
    Location: Room 32

    Presenter: Chike Abana, MD, PhD – The University of Texas M.D. Anderson Cancer Center

  • 8:30 AM – 8:37 AM PT
    113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal Injury
    Location: Room 32

    Presenter: Haiyan Lu, MD – The Second Affiliated Hospital of Soochow University

  • 8:30 AM – 8:37 AM PT
    113 - Gut Microbiota-Derived D-Tagatose from EGCG Attenuates Radiation-Induced Intestinal Injury
    Location: Room 32

    Presenter: Ye Tian, MD – The Second Affiliated Hospital of Soochow University

  • 8:40 AM – 8:47 AM PT
    114 - HDAC-Mediated Glial Crosstalk Mediates Radiation Induced Memory Changes from Whole Brain Radiation in a Mouse Model
    Location: Room 32

    Presenter: Peter Mathen, MD – NIH/NCI

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 32

    Discussant: Deborah Citrin, MD, FASTRO – NIH/NCI

  • 8:00 AM – 8:07 AM PT
    105 - Clinical Validation of HPV ctDNA for Early Detection of Residual Disease Following Chemoradiation in Cervical Cancer
    Location: Room 5

    Presenter: Kathy Han, MD, MS – Princess Margaret Cancer Center, University Health Network

  • 8:10 AM – 8:17 AM PT
    106 - Prognostic Impact of Mismatch Repair Deficiency on Stage I-II Endometrioid Endometrial Cancer Treated with Adjuvant Radiation Therapy: A Multi-Institutional Analysis
    Location: Room 5

    Presenter: Zohaib Sherwani, MD – Rutgers Cancer Institute of New Jersey

  • 8:20 AM – 8:27 AM PT
    107 - HPV Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation
    Location: Room 5

    Presenter: Aaron Seo, MD, PhD – MD Anderson Cancer Center

  • 8:30 AM – 8:37 AM PT
    108 - A Cost-Effective, Machine Learning-Based New Unified Risk-Classification Score (NU-CATS) for Patients with Endometrial Cancer
    Location: Room 5

    Presenter: Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine

  • 8:40 AM – 8:47 AM PT
    109 - Mutational Landscape of ER Receptor Negative Endometrial Cancer Patients Categorized as No Specific Molecular Profile (NSMP)
    Location: Room 5

    Presenter: Michael Waters, MD, PhD – Washington University St. Louis

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 5

    Discussant: Lara Hathout, MD, FRCPC – Rutgers Cancer Institute of New Jersey

  • 8:05 AM – 8:10 AM PT
    1000 - Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results
    Location: Room 8

    Presenter: Peter Hoskin, MD – Mount Vernon Hospital

  • 8:10 AM – 8:15 AM PT
    1002 - Long-Term Outcomes of Prospective Clinical Trial HDR-Brachytherapy Monotherapy in Single Day in Patients with Localizated Prostate Cancer
    Location: Room 8

    Presenter: Elena Moreno-Olmedo, MD – Genesiscare UK (Oxford)

  • 8:15 AM – 8:20 AM PT
    1004 - Stereotactic Ablative Radiotherapy Boost to Bladder Tumor for Bladder Preservation in Patients with Muscle-Invasive Bladder Cancer
    Location: Room 8

    Presenter: Shang-Bin Qin, MD

  • 8:20 AM – 8:25 AM PT
    1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis
    Location: Room 8

    Presenter: Gamze Ugurluer, MD – Acibadem Adana Hospital

  • 8:20 AM – 8:25 AM PT
    1006 - Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis
    Location: Room 8

    Presenter: Enis Ozyar, MD – Acibadem Maslak Hospital

  • 8:25 AM – 8:30 AM PT
    1008 - Prospective Comparative Study of Quality of Life in Bladder Cancer Patients Undergoing Cystectomy or Bladder Preservation
    Location: Room 8

    Presenter: Vedang Murthy, MD – Tata Memorial Centre

  • 8:30 AM – 8:40 AM PT
    1010 - Prognostication of Overall Survival in Muscle Invasive Bladder Cancer: An Application of a Lymph Node Metastasis Nomogram
    Location: Room 8

    Presenter: Garrett Harada, MD – UCI Health

  • 9:30 AM – 9:40 AM PT
    3 - Consolidative Radiotherapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab Vedoti
    Location: Ballroom 20

    Presenter: Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida

  • 9:40 AM – 9:50 AM PT
    4 - Association between Regular Vaginal Dilation and/or Sexual Activity and Long-Term Vaginal Morbidity in Cervical Cancer Survivors
    Location: Ballroom 20

    Presenter: Kathrin Kirchheiner, PhD, MSc – Medical University of Vienna

  • 9:50 AM – 10:00 AM PT
    5 - TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II)
    Location: Ballroom 20

    Presenter: Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre

  • 10:00 AM – 10:10 AM PT
    6 - Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
    Location: Ballroom 20

    Presenter: W. Robert Lee, MD, MS, FASTRO, MEd – Duke University Medical Center

  • 10:10 AM – 10:20 AM PT
    7 - Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2Gy) vs. Standard Dose (70.2Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer
    Location: Ballroom 20

    Presenter: Jeff Michalski, MD, MBA, FASTRO – Washington University St. Louis

  • 10:20 AM – 10:30 AM PT
    Discussant
    Location: Ballroom 20

    Discussant: Dayssy Diaz Pardo, MD, MS – The Ohio State University

  • 10:20 AM – 10:30 AM PT
    LBA 05 - Patient-Reported and Toxicity Results from the FABREC Study: A Multicenter Randomized Trial of Hypofractionated vs. Conventionally-Fractionated Postmastectomy Radiation Therapy After Implant-Based Rec
    Location: Ballroom 20

    Presenter: Rinaa Punglia, MD, FASTRO, MPH – Dana-Farber Cancer Institute

  • 10:30 AM – 10:40 AM PT
    LBA 06 - Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in Men with High-Risk Biochemically Recurrent Prostate Cancer and Prior Radiotherapy: EMBARK Subgroup Analysis
    Location: Ballroom 20

    Presenter: Swetha Sridharan, MBBS – Calvary Mater Newcastle Hospital

  • 10:40 AM – 10:50 AM PT
    LBA 07 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) Trial
    Location: Ballroom 20

    Presenter: Denise Bernhardt, MD – Technical University of Munich (TUM), Radiation Oncology

  • 4:50 PM – 4:55 PM PT
    1012 - Development and Evaluation of a Mobile App for Radiotherapy Patient Education
    Location: Room 8

    Presenter: Jose Felipe Munoz Lozano, MD – Hospital Universitario

  • 4:55 PM – 5:00 PM PT
    1014 - Association of Parental Status and Gender with Burden of Multidisciplinary Tumor Boards
    Location: Room 8

    Presenter: Brittney Chau, MD – USC

  • 5:00 PM – 5:05 PM PT
    1016 - Teaching Trainees to be Effective Mentors: A Needs-Based Assessment in Radiation Oncology
    Location: Room 8

    Presenter: Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber

  • 5:05 PM – 5:10 PM PT
    1018 - Quality of Life In Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac
    Location: Room 8

    Presenter: Sara Beltran Ponce, MD – Medical College of Wisconsin

  • 5:10 PM – 5:15 PM PT
    1020 - A Randomized Standard-of-Care Controlled Trial of Xenogeneic Platelet-Rich Plasma Lotion to Reduce Acute Radiation Dermatitis in Breast Cancer Patients
    Location: Room 8

    Presenter: Chun-Shu Lin, MD, PhD – Tri-Service General Hospital

  • 5:15 PM – 5:20 PM PT
    1022 - Harnessing Electronic Patient-Reported Outcomes (ePRO) in Routine Care to Promote Clinical Trial Enrollment: A Randomized Study
    Location: Room 8

    Presenter: Nicholas Verdini, BS – Tufts University School of Medicine

  • 4:45 PM – 4:52 PM PT
    115 - Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-Gastric Diseases (PROCEED): Assessment of Pathologic Response in a Prospective, Phase II Single-Arm Trial
    Location: Room 1

    Presenter: Pooja Karukonda, MD – Duke Cancer Institute

  • 4:55 PM – 5:02 PM PT
    116 - Prospective Trial of Using Imaging to Predict Pathologic Response and Clinical Outcomes in Locally Advanced Esophageal Cancer
    Location: Room 1

    Presenter: Yufei Liu, MD, PhD – City of Hope

  • 5:05 PM – 5:12 PM PT
    117 - Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical Trial
    Location: Room 1

    Presenter: Yang Yang, MD, DO, PhD – Zhejiang Cancer Hospital

  • 5:15 PM – 5:22 PM PT
    118 - Electrocardiogram with Artificial Intelligence Assessment as a Predictor of Cardiac Events and Overall Survival in Patients Receiving Radiotherapy for Esophageal Cancer
    Location: Room 1

    Presenter: Roman Kowalchuk, MD, BS – Mayo Clinic College of Medicine and Science Rochester

  • 5:25 PM – 5:32 PM PT
    119 - Utilization of the Triangle Volume in Patients with Localized PDAC Undergoing Pre-Operative SBRT: Report of Early Outcomes
    Location: Room 1

    Presenter: Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center

  • 5:35 PM – 5:42 PM PT
    120 - Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer
    Location: Room 1

    Presenter: Michael Chuong, MD – Miami Cancer Institute

  • 5:45 PM – 5:55 PM PT
    Discussant
    Location: Room 1

    Discussant: Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center

  • 4:45 PM – 4:52 PM PT
    127 - Deep Learning-Based Natural Language Processing to Automate Esophagitis Severity Grading from the Electronic Health Records
    Location: Room 32

    Presenter: Shan Chen, MS – Harvard Medical School

  • 4:55 PM – 5:02 PM PT
    128 - Operational Ontology for Radiation Oncology (OORO): A Professional Society-Based, Multi-Stakeholder Consensus Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data
    Location: Room 32

    Presenter: Amanda Caissie

  • 5:05 PM – 5:12 PM PT
    129 - A Prospective Study of Machine Learning-Assisted Radiotherapy Planning for Patients Receiving 54 Gy to the Brain
    Location: Room 32

    Presenter: Derek Tsang, MD, MS – Princess Margaret Cancer Centre

  • 5:15 PM – 5:22 PM PT
    130 - Curietherapy User eXperience Pilot Study: A Novel Augmented Reality Educational Tool during Radiation Oncology Consultation for Patients with Breast Cancer
    Location: Room 32

    Presenter: David Byun, MD – NYU Grossman School of Medicine

  • 5:25 PM – 5:32 PM PT
    131 - Improving Dose Volume Histogram (DVH) Based Analysis of Clinical Outcomes Using Modern Statistical Techniques: A Systematic Answer to Multiple Comparisons Concerns
    Location: Room 32

    Presenter: Mirek Fatyga, PhD – Mayo Clinic Arizona

  • 5:35 PM – 5:42 PM PT
    132 - Clinical Acceptability of Artificial Intelligence-Screened Interstitial Lung Disease (AI-ILD) in Lung Cancer Patients Treated with Radiotherapy
    Location: Room 32

    Presenter: Nicholas McNeil, MBBS – University of Toronto

  • 5:45 PM – 5:55 PM PT
    Discussant
    Location: Room 32

    Discussant: Danielle Bitterman, MD – Brigham and Women's Hospital

  • 4:45 PM – 4:52 PM PT
    121 - Building a Diverse Pathway into Radiation Oncology: The Initial 12-Year Experience of the ASTRO Medical Student Fellowship Program for Underrepresented Populations
    Location: Room 4

    Presenter: Kekoa Taparra, MD, PhD – Stanford Health Care

  • 4:55 PM – 5:02 PM PT
    122 - The Impact of a Precision Medicine Navigator on Inequities Associated with Utilization of Genomic Tests in Black Men with Prostate Cancer
    Location: Room 4

    Presenter: Alexander Allen, MD – University of Maryland Medical Center

  • 5:05 PM – 5:12 PM PT
    123 - Improving Sexual Orientation and Gender Identity Documentation at an NCI-Designated Comprehensive Cancer Center
    Location: Room 4

    Presenter: Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center

  • 5:15 PM – 5:22 PM PT
    124 - State Mandatory Paid Family Leave and Survival among Children with Cancer
    Location: Room 4

    Presenter: Justin Barnes, MD, MS – Washington University School of Medicine

  • 5:25 PM – 5:32 PM PT
    125 - Under-Representation for Female Cancers in Commercial Auto-Segmentation Solutions and Open-Source Imaging Datasets
    Location: Room 4

    Presenter: Maria Thor, PhD, MS – Memorial Sloan Kettering Cancer Center

  • 5:35 PM – 5:42 PM PT
    126 - Impact of Free Hospital-Provided Rideshare Service on Radiation Therapy Completion Rates: A Matched Cohort Analysis
    Location: Room 4

    Presenter: Eric Chen, MD – University Hospitals Seidman Cancer Center

  • 5:45 PM – 5:55 PM PT
    Discussant
    Location: Room 4

    Discussant: Idalid Franco, MD, MPH – Dana-Farber/Brigham and Women's Cancer Center

  • Monday, October 2, 2023
  • 8:10 AM – 8:17 AM PT
    134 - Cell-Free DNA Fragmentomics for Early Detection of Malignant Transformation in NF1 Patients Harboring Plexiform Neurofibromas
    Location: Room 4

    Presenter: Aadel Chaudhuri, MD, PhD – Washington University in St. Louis

  • 8:20 AM – 8:27 AM PT
    135 - Proteogenomic Analysis of Human Uterine Cervical Cancer (UCC) Reveals Treatment-Resistant Subtypes of UCC
    Location: Room 4

    Presenter: Joo-Young Kim, MD, PhD – National Cancer Center

  • 8:30 AM – 8:37 AM PT
    136 - Prognostic Significance of Pretreatment Immune Cell Infiltration in Muscle Invasive Bladder Cancer Treated with Definitive Chemoradiation: Analysis of NRG RTOG 0524 and 0712
    Location: Room 4

    Presenter: Matthew Deek, MD – Rutgers University

  • 8:40 AM – 8:47 AM PT
    137 - Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC
    Location: Room 4

    Presenter: Liam Spurr, BS – University of Chicago Pritzker School of Medicine

  • 8:50 AM – 8:57 AM PT
    138 - Comprehensive Genomic Analysis Stratified by KRAS Status in Patients with Pancreatic Adenocarcinoma and Its Prognostic Significance
    Location: Room 4

    Presenter: Jongmyung Kim, MD, PhD – Rutgers Cancer Institute of New Jersey

  • 8:05 AM – 8:10 AM PT
    1024 - Synthetic MRI-Assisted and Self-Supervised Adaptive Segmentation of Organs-at-Risk (OARs) in MRI-Based Radiation Therapy
    Location: Room 8

    Presenter: Reza Kalantar, PhD, MS, BS – The Institute of Cancer Research

  • 8:10 AM – 8:15 AM PT
    1026 - Crowdsourcing Deep Learning Algorithms to Automatically Contour GI Luminal Organs on Serial MRIs
    Location: Room 8

    Presenter: Sangjune Lee, MD, MS, BS, FRCPC DABR – University of Calgary

  • 8:15 AM – 8:20 AM PT
    1028 - Contouring Analysis on Synthetic Contrast-Enhanced MR from GRMM-GAN and Implications on MR-Guide Radiation Therapy
    Location: Room 8

    Presenter: Wensha Yang, PhD – University of California San Francisco

  • 8:20 AM – 8:25 AM PT
    1030 - Deep Learning-Based Pipeline for Automatic Identification of Intestinal Regenerating Crypts in Mouse Histological Images
    Location: Room 8

    Presenter: Jie Fu, PhD – University of Washington

  • 8:25 AM – 8:30 AM PT
    1032 - Towards Automated Dosimetric Analysis of the Bladder Trigone: Deep-Learning-Based Joint Segmentation and Landmark Localization
    Location: Room 8

    Presenter: Hengjie Liu, BS – UCLA

  • 8:30 AM – 8:35 AM PT
    1034 - Organ Specific Deep Learning-Based Correction of Inaccurate Auto-Segmentation on Abdominal MRI
    Location: Room 8

    Presenter: Christina Sarosiek, PhD – Medical College of Wisconsin

  • 10:50 AM – 10:55 AM PT
    1048 - A Prospective Study Evaluating Sexual Health Outcomes in Patients Undergoing (Chemo)Radiation (CRT/RT) for Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC)
    Location: Room 7

    Presenter: Lachlan Joseph McDowell, MB, BS, MBBS, FRANZCR – Princess Alexandra Hospital

  • 10:55 AM – 11:00 AM PT
    1050 - Patient-Reported Outcomes Evaluating the Impact of Hypo-Fractionated Palliative Quadshot Radiotherapy and Concurrent CDDP Treatment on Health-Related Quality of Life in Patients with Locally Advanced
    Location: Room 7

    Presenter: Jhansi Pattanaik, MD, MBBS – All India Institute of Medical Sciences

  • 11:00 AM – 11:05 AM PT
    1052 - Hearing Outcomes in Cisplatin or Cetuximab Combined with Radiation for Patients with HPV-Associated Oropharyngeal Cancer in NRG/RTOG 1016
    Location: Room 7

    Presenter: Christina Runge, PhD – Medical College of Wisconsin

  • 11:05 AM – 11:10 AM PT
    1054 - Natural History and Clinical/Dosimetric Determinants of Osteoradionecrosis in a Large Cohort of Head and Neck Cancer Following Curative Radiotherapy: Debunking the Myth of Decreased Rates of Osteoradi
    Location: Room 7

    Presenter: Abdallah Mohamed, MD, PhD – MD Anderson Cancer Center

  • 11:10 AM – 11:15 AM PT
    1056 - Long-Term Outcomes of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
    Location: Room 7

    Presenter: Ryan Morse, MD – University of North Carolina at Chapel Hill

  • 11:15 AM – 11:20 AM PT
    1058 - Brachial Plexus Tolerance to Standard Fractionation Re-Irradiation: The Ohio State University Experience
    Location: Room 7

    Presenter: Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute

  • 10:55 AM – 11:00 AM PT
    1038 - TFAM Modulates Cardiomyocytes Pyroptosis Induced by Ionizing Radiation through mtDNA/TLR9/NF-kB Pathway
    Location: Room 8

    Presenter: Guoxin Cai, MD – Shandong Cancer Hospital and Institute

  • 11:00 AM – 11:05 AM PT
    1042 - Single-Cell RNA Sequencing Reveals a Subset of cMAS can Aggravate RIHD through CXCL1-CXCR2 Axis
    Location: Room 8

    Presenter: Dawei Chen, MD, MB

  • 11:05 AM – 11:10 AM PT
    1044 - HPK1 Inhibition Enhances HXRT Anti-Tumor Immune Response by Regulating RGS16 to Restore Functionality in Tumor-Infiltrating Exhausted CD8+T Cells
    Location: Room 8

    Presenter: Dawei Chen, MD, MB

  • 11:10 AM – 11:15 AM PT
    1046 - Bifunctional Role of Monocyte Subsets in Modulating Radiotherapy Combined Intra-Tumor aCD40 Agonist Induced Abscopal Effect
    Location: Room 8

    Presenter: Yue Zhao, MD, PhD – China

  • 10:45 AM – 10:52 AM PT
    151 - Dosimetry Reconstruction in Radiopharmaceutical Therapy Using a Sparse Network of External ?-Sensors
    Location: Room 30 A/B/C

    Presenter: Rahul Lall, BS – University of California, Berkeley

  • 10:55 AM – 11:02 AM PT
    152 - Long-Term Results of a Multi-Institutional Study of Dynamic Tumor Tracking-Stereotactic Body Radiotherapy for Lung Tumors
    Location: Room 30 A/B/C

    Presenter: Yukinori Matsuo, MD, PhD – Kindai University Faculty of Medicine

  • 11:05 AM – 11:12 AM PT
    153 - Assessment of Dynamic Contrast Enhanced (DCE) MRI for Detection of Radiotherapy Induced Alteration in Mandibular Vasculature
    Location: Room 30 A/B/C

    Presenter: Moamen Abobakr, MD – MD Anderson Cancer Center

  • 11:15 AM – 11:22 AM PT
    154 - Theranostic Nanoparticle Uptake in Patient Brain Tumors as Quantified by MP2RAGE T1 Mapping
    Location: Room 30 A/B/C

    Presenter: Stephanie Bennett, PhD – Massachusetts General Brigham

  • 11:25 AM – 11:32 AM PT
    155 - The Microvascular Health Status Predicts Radio-Induced Acute Toxicities in Breast, Prostate and Head and Neck Cancer Patients
    Location: Room 30 A/B/C

    Presenter: Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori

  • 11:35 AM – 11:42 AM PT
    156 - Auto-Correction for Inaccurate Auto-Segmentation of Abdominal MRI by Combining Deep Learning and Active Contour Method
    Location: Room 30 A/B/C

    Presenter: Mohammad Zarenia, PhD – Medical College of Wisconsin

  • 10:45 AM – 10:52 AM PT
    145 - Prospective Phase II Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed By Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small
    Location: Room 6 D/E

    Presenter: John Heinzerling, MD, OCN – Southeast Radiation Oncology Group PA

  • 10:55 AM – 11:02 AM PT
    146 - Adaptive Radiotherapy Guided by PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase II Randomized Study
    Location: Room 6 D/E

    Presenter: Yaoyao Zhu, MS, RT – Shanghai Pulmonary Hospital

  • 10:55 AM – 11:02 AM PT
    146 - Adaptive Radiotherapy Guided by PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase II Randomized Study
    Location: Room 6 D/E

    Presenter: Yaping Xu, PhD – Shanghai Pulmonary Hospital

  • 11:05 AM – 11:12 AM PT
    147 - Assessment of Precision Irradiation in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (ASPIRE-ILD): Primary Analysis of a Phase II Trial
    Location: Room 6 D/E

    Presenter: David Palma, MD, PhD – London Health Sciences Centre

  • 11:15 AM – 11:22 AM PT
    148 - Dosimetric Impact of Systematic Mediastinal Staging via Endobronchial Ultrasound for Patients with Locally Advanced Lung Cancer: The SEISMIC Trial
    Location: Room 6 D/E

    Presenter: Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre

  • 11:25 AM – 11:32 AM PT
    149 - Circulating Tumor DNA for Early Risk Stratification of Oligometastatic Lung Cancer
    Location: Room 6 D/E

    Presenter: Aadel Chaudhuri, MD, PhD – Washington University in St. Louis

  • 11:35 AM – 11:42 AM PT
    150 - Residual ctDNA Detection Predicts Benefit From Definitive Chemoradiotherapy and Immune Checkpoint Inhibitors in Locally Advanced NSCLC
    Location: Room 6 D/E

    Presenter: Yu Wang, MD – Chinese Academy of Medical Sciences and Peking Union Medical College

  • 11:45 AM – 11:55 AM PT
    Discussant
    Location: Room 6 D/E

    Discussant: Jeffrey Bradley, MD, FASTRO – University of Pennsvania Radiation Oncology

  • 10:45 AM – 10:52 AM PT
    139 - Quality of Life Results of Addition of Androgen Deprivation Therapy and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy: NRG Oncology/RTOG 0534 SPPORT
    Location: Room 6 C/F

    Presenter: Deborah Bruner, PhD, RN, FAAN – Nell Hodgson Woodruff School of Nursing

  • 10:45 AM – 12:00 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Cynthia Menard, MD – University of Montreal Hospital (CHUM)

  • 10:55 AM – 11:02 AM PT
    140 - Final Analysis of a Phase III Controlled Randomized Study of Stereotactic Body Proton Therapy or Conventionally Fractionated Proton Therapy for Early Prostate Cancer: PCG GU002
    Location: Room 6 C/F

    Presenter: Diego Toesca, MD – Mayo Clinic Arizona

  • 11:05 AM – 11:12 AM PT
    141 - Conventional vs. Hypo-Fractionated, Radiotherapy for High-Risk Prostate Cancer (PCS5), Randomized, Non-Inferiority, Phase 3 Trial: Posthoc Analysis of IMRT vs. 3D-CRT Radiation Therapy Associated Toxi
    Location: Room 6 C/F

    Presenter: Constanza Martinez, MD, PhD – McGill University Health Centre

  • 11:15 AM – 11:22 AM PT
    142 - Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate
    Location: Room 6 C/F

    Presenter: Tamim Niazi, MD – McGill University

  • 11:25 AM – 11:32 AM PT
    143 - Progression-Directed Therapy in Oligoprogressive Castration-Refractory Prostate Cancer: Results of the Prospective Single-Arm Phase II MEDCARE Trial
    Location: Room 6 C/F

    Presenter: Gert De Meerleer, MD, PhD – UZ Leuven

  • 11:35 AM – 11:42 AM PT
    144 - The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study
    Location: Room 6 C/F

    Presenter: Ragu Ratnakumaran, MBBS – Royal Marsden NHS Foundation Trust

  • 1:30 PM – 1:40 PM PT
    LBA 04 - Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)
    Location: Ballroom 20

    Presenter: Vinai Gondi, MD – Northwestern Medicine Cancer Center Warrenville and Proton Center

  • 1:40 PM – 1:50 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Debra Yeboa, MD – MD Anderson Cancer Center

  • 1:50 PM – 2:00 PM PT
    1 - High Dose Hyperfractionated Thoracic Radiotherapy vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 Trial
    Location: Ballroom 20

    Presenter: Jiayi Yu, PhD – Peking University Cancer Hospital and Institute

  • 2:00 PM – 2:10 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Kristin Higgins, MD – Winship Cancer Institute of Emory University

  • 2:10 PM – 2:20 PM PT
    LBA 03 - 5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated Exte
    Location: Ballroom 20

    Presenter: Nicholas van As, MD, MB – The Royal Marsden NHS Foundation Trust

  • 2:20 PM – 2:30 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Alejandro Berlin, MD, MS – Princess Margaret Cancer Centre

  • 2:30 PM – 2:40 PM PT
    LBA 01 - Randomized Phase III Trial of Postoperative Radiotherapy with or without Cetuximab for Intermediate-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN): NRG/RTOG 0920
    Location: Ballroom 20

    Presenter: Mitchell Machtay, MD, FASTRO – Penn State Hershey Medical Center

  • 2:40 PM – 2:50 PM PT
    LBA 02 - Randomized Controlled Trial of Hypofractionated vs. Normo-fractionated Accelerated Radiation Therapy with or without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO)
    Location: Ballroom 20

    Presenter: Soren Bentzen, DSc, PhD, FASTRO – University of Maryland School of Medicine

  • 2:50 PM – 3:00 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Christina Chapman, MD, MS – Baylor College of Medicine

  • 3:00 PM – 3:07 PM PT
    157 - Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial
    Location: Room 6 D/E

    Presenter: Alexander Sherry, MD – University of Texas MD Anderson Cancer Center

  • 3:10 PM – 3:17 PM PT
    158 - Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer
    Location: Room 6 D/E

    Presenter: Ryan Phillips, MD, PhD – The Mayo Clinic

  • 3:20 PM – 3:27 PM PT
    159 - Cross-Comparison Individual Patient Level Analysis of Three Gene Expression Signatures in Localized Prostate in over 50,000 Men
    Location: Room 6 D/E

    Presenter: Angela Jia, MD, PhD – Case Western Reserve University/University Hospitals Cleveland Medical Center

  • 3:30 PM – 3:37 PM PT
    160 - Detection Rate of 18F-rhPSMA-7.3 PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels <1 ng/mL: Data from the Phase 3 SPOTLIGHT Study
    Location: Room 6 D/E

    Presenter: Ashesh Jani, MD, FASTRO – Emory University

  • 3:40 PM – 3:47 PM PT
    161 - PSMA-Positive Extracellular Vesicles Predict Disease Recurrence in Oligometastatic Castration-Sensitive Prostate Cancer Treated with Stereotactic Ablative Radiotherapy: Analysis of the ORIOLE trial
    Location: Room 6 D/E

    Presenter: Edlira Horjeti, MD, MBBS – Mayo Clinic

  • 3:50 PM – 4:00 PM PT
    Discussant
    Location: Room 6 D/E

    Discussant: Osama Mohamad, MD, PhD – MD Anderson Cancer Center

  • 3:00 PM – 3:07 PM PT
    173 - Combination of BET Inhibition with Radiation Induces Anti-Tumor Immune Response in Pre-Clinical Models of ER-Positive Breast Cancer
    Location: Room 30 D/E

    Presenter: Prasanna Alluri, MD, PhD – UT Southwestern Medical Center at Dallas

  • 3:10 PM – 3:17 PM PT
    174 - CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in Glioblastoma
    Location: Room 30 D/E

    Presenter: S. John Liu, MD, PhD – UCSF

  • 3:20 PM – 3:27 PM PT
    175 - In Silico Discovery and Investigation of Novel Small Molecules Targeting PSMA7 for the Treatment of GBM
    Location: Room 30 D/E

    Presenter: Christian Showalter, PhD – The Ohio State University

  • 3:30 PM – 3:37 PM PT
    176 - Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy
    Location: Room 30 D/E

    Presenter: Anam Kesaria, MD – UAMS Radiation Oncology

  • 3:40 PM – 3:47 PM PT
    177 - Targeting Non-Kinase Function of CDK6 to Overcome CDK4/6 Inhibitor Resistance
    Location: Room 30 D/E

    Presenter: Prasanna Alluri, MD, PhD – UT Southwestern Medical Center at Dallas

  • 3:50 PM – 3:57 PM PT
    178 - Nanobody-Based ImmunoPET for Hepatocellular Carcinoma
    Location: Room 30 D/E

    Presenter: Stanley Fayn, BS – National Cancer Institute

  • 3:00 PM – 3:07 PM PT
    168 - Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer: Primary Endpoint Results of the SAVE Randomized Clinical Trial
    Location: Room 31

    Presenter: Gita Suneja, MD, MS – University of Utah Huntsman Cancer Institute

  • 3:10 PM – 3:17 PM PT
    169 - Toripalimab Combined with Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients: Early Results of Safety and Feasibility
    Location: Room 31

    Presenter: Dan Ou, MD

  • 3:20 PM – 3:27 PM PT
    170 - Evaluating the Effects of Bone Marrow Sparing Radiotherapy on Acute Hematologic Toxicity for Patients with Locoregionally Advanced Cervical Cancer: A Prospective Phase II Randomized Controlled Trial
    Location: Room 31

    Presenter: Wen Li, PhD candidate – West China Second University Hospital

  • 3:30 PM – 3:37 PM PT
    171 - HYPOCx-iRex (TCTR20210812003) A Phase II RCT: 44Gy/20F VS 45Gy/25F CCRT in Cervical Cancer - 6-mo Post-RT Update
    Location: Room 31

    Presenter: Tissana Prasartseree, MD – Siriraj Hospital Mahidol University

  • 3:40 PM – 3:47 PM PT
    172 - Multiple Sessions vs. Single Session Image-Based Intracavitary Brachytherapy for Locally Advanced Cervical Cancer - A Randomized Control Trial
    Location: Room 31

    Presenter: Daya Nand Sharma, MD, PhD – AIIMS New Delhi

  • 3:48 PM – 3:58 PM PT
    Discussant
    Location: Room 31

    Discussant: Katherine Tzou, MD – University of Colorado Anschutz Medical Campus

  • 3:00 PM – 3:07 PM PT
    162 - Radiochemical Oxygen Depletion Depends on Chemical Environment and Dose-Rate: Implications for FLASH Effect
    Location: Room 30 A/B/C

    Presenter: Rodney Wiersma, PhD – University of Pennsylvania

  • 3:10 PM – 3:17 PM PT
    163 - A Novel Planning and Delivery Technology: Dose, Dose Rate and Linear Energy Transfer(LET) Optimization Based on Spot-Scanning Proton Arc Therapy FLASH (SPLASHLET)
    Location: Room 30 A/B/C

    Presenter: Gang Liu, PhD – Beaumont Health System

  • 3:10 PM – 3:17 PM PT
    163 - A Novel Planning and Delivery Technology: Dose, Dose Rate and Linear Energy Transfer(LET) Optimization Based on Spot-Scanning Proton Arc Therapy FLASH (SPLASHLET)
    Location: Room 30 A/B/C

    Presenter: Xiaoqiang Li, PhD – William Beaumont Hospital

  • 3:20 PM – 3:27 PM PT
    164 - An Effective Dose Rate Optimization Algorithm for Efficient Conventional-Dose-Rate Proton Therapy and Ultra-High-Dose-Rate FLASH Proton Therapy
    Location: Room 30 A/B/C

    Presenter: Yuting Lin, PhD – University of Kansas Medical Center

  • 3:30 PM – 3:37 PM PT
    165 - Towards Clinical Proton Minibeam Radiation Therapy (pMBRT): Development of Clinical pMBRT System Prototype and pMBRT-Specific Treatment Planning Method
    Location: Room 30 A/B/C

    Presenter: Hao Gao, PhD – University of Kansas Medical Center

  • 3:40 PM – 3:47 PM PT
    166 - Towards Clinical Translation of Microbeam Radiation Therapy (MRT) with a Compact Source
    Location: Room 30 A/B/C

    Presenter: Stefan Bartzsch, PhD

  • 3:50 PM – 3:57 PM PT
    167 - Spot Scanning Proton Therapy for Pregnant Patients with Brain and Head and Neck Tumors
    Location: Room 30 A/B/C

    Presenter: Justine Dupere, PhD – Mayo Clinic

  • 3:05 PM – 3:10 PM PT
    1060 - Implementation Outcomes of Strategies to Promote Short-Course Radiation for Nonspine Bone Metastases in an Academic-Community Partnership: Survey Results from the ALIGNMENT Trial
    Location: Room 8

    Presenter: Patricia Santos, MD, MS – Memorial Sloan Kettering Cancer Center

  • 3:15 PM – 3:20 PM PT
    1064 - Patient and Caregivers Opinions on Receiving Radiology Results before Oncologist Appointments
    Location: Room 8

    Presenter: Nicholas Eustace, MD, PhD, BS – City of Hope National Medical Center

  • 3:20 PM – 3:25 PM PT
    1066 - Do Physician Patient Sharing Networks Impact Disparities in Access to Multidisciplinary Cancer Consultation for Early Stage Lung Cancer? A SEER-Medicare Network Analysis
    Location: Room 8

    Presenter: Nirav Kapadia, MD, MS – Dartmouth-Hitchcock Medical Center

  • 3:25 PM – 3:30 PM PT
    1068 - Multi-Institutional Fact-Finding Study: Association between Geriatric Assessment and Reduction in Intensity of Radiotherapy for Elderly Cancer Patients without Metastasis
    Location: Room 8

    Presenter: Keiko Murofushi, MD, PhD – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

  • 3:30 PM – 3:35 PM PT
    1070 - Radiotherapy Access and Treatment in Rwanda: Demographics and Clinical Characteristics of Cervical Cancer Patients
    Location: Room 8

    Presenter: Timothy Davis, BS – Albert Einstein College of Medicine

  • 5:00 PM – 5:07 PM PT
    179 - Is it the Type of Axillary Surgery or the Number of Removed Lymph Nodes That Increases the Risk of Breast Cancer Related Lymphedema (BCRL)? Results from a Prospective Screening Trial
    Location: Room 6 C/F

    Presenter: George Naoum, MD, MS – Massachusetts General Hospital

  • 5:09 PM – 5:16 PM PT
    180 - Increased Complication Rates with Proton Therapy in Breast Cancer Patients with Immediate, Implant-Based Reconstruction: Single-Institution Comparative Effectiveness Analysis
    Location: Room 6 C/F

    Presenter: Alphonse Taghian, MD, PhD, FASTRO – Massachusetts General Hospital

  • 5:18 PM – 5:25 PM PT
    181 - Risk of Radiation-Associated Secondary Malignancies Among Patients with Breast Cancer Harboring TP53 Germline Variants
    Location: Room 6 C/F

    Presenter: Gustav Cederquist, MD, PhD – Memorial Sloan Kettering Cancer Center

  • 5:27 PM – 5:34 PM PT
    182 - Early Results of the French Multicenter, Randomized SHARE Trial Comparing Whole Breast Irradiation vs. Accelerated Partial Breast Irradiation in Postmenopausal Women with Early-Stage Breast Cancer
    Location: Room 6 C/F

    Presenter: Yazid Belkacemi, MD, PhD – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII

  • 5:36 PM – 5:43 PM PT
    183 - Comparison between Pre-Pectoral and Post-Pectoral Implant Reconstruction and Different Radiation Modalities on Breast Reconstruction Complications
    Location: Room 6 C/F

    Presenter: George Naoum, MD, MS – Massachusetts General Hospital

  • 5:45 PM – 5:52 PM PT
    184 - Effectiveness and Toxicity of Five Fraction Prone Accelerated Partial Breast Irradiation
    Location: Room 6 C/F

    Presenter: Camille Hardy Abeloos, MD – NYU Grossman School of Medicine

  • 5:54 PM – 5:58 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Rachel Rabinovitch, MD, FASTRO – University of Colorado Denver

  • 5:54 PM – 6:00 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Jean Wright, MD, FASTRO – Johns Hopkins University

  • 5:00 PM – 5:07 PM PT
    191 - Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: An ILROG Multi-Institutional Study
    Location: Room 31

    Presenter: Nikhil Yegya-Raman, MD – University of Pennsylvania Health System

  • 5:10 PM – 5:17 PM PT
    192 - Phase I Trial of Re-Priming Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Location: Room 31

    Presenter: Kiran Kumar, MD, MBA – UT Southwestern Medical Center

  • 5:20 PM – 5:27 PM PT
    193 - Consolidative Radiotherapy for Residual PET-Avid Disease on Day +30 Post CAR T-Cell Therapy in Non-Hodgkin Lymphoma
    Location: Room 31

    Presenter: Omran Saifi, MD – Mayo Clinic Florida

  • 5:30 PM – 5:37 PM PT
    194 - Prognostic Significance of Positron Emission Tomography Delta Radiomics Following Bridging Therapy in Patients with Large B-Cell Lymphoma Undergoing CAR T-Cell Therapy
    Location: Room 31

    Presenter: Colton Ladbury, MD, BS – City of Hope National Medical Center

  • 5:40 PM – 5:47 PM PT
    195 - Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas
    Location: Room 31

    Presenter: Gohar Manzar, MD, PhD – MD Anderson Cancer Center

  • 5:50 PM – 6:00 PM PT
    Discussant
    Location: Room 31

    Discussant: Timothy Robinson, MD, PhD – Yale Therapeutic Radiology

  • 5:00 PM – 5:07 PM PT
    185 - Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning
    Location: Room 1

    Presenter: Lianli Liu, PhD – Stanford University

  • 5:10 PM – 5:17 PM PT
    186 - Heatmaps to Assess Tumor Motion Probability with MRcine in Head and Neck Cancer
    Location: Room 1

    Presenter: Yonatan Weiss, MD – Miami Cancer Institute

  • 5:20 PM – 5:27 PM PT
    187 - Principal Component Analysis to Design Planning Target Volume in Oropharyngeal Cancers
    Location: Room 1

    Presenter: Mona Arbab, MD, M.Ed – UT Southwestern Medical Center

  • 5:30 PM – 5:37 PM PT
    188 - Reduction of Late Urinary Toxicity from Prostate Cancer Radiotherapy via Intrafractional MV-kV Image Guidance
    Location: Room 1

    Presenter: Pengpeng Zhang, PhD – Memorial Sloan Kettering Cancer Center

  • 5:40 PM – 5:47 PM PT
    189 - Deep Learning-Based Single-View Fluorescence Dose Reconstruction for 3D Dosimetry
    Location: Room 1

    Presenter: Yusuke Nomura, PhD – Stanford University

  • 5:50 PM – 5:57 PM PT
    190 - Deep Learning-Based Automated Quality Assurance for Palliative Spinal Treatment Planning in Radiotherapy
    Location: Room 1

    Presenter: Christopher Kehayias, PhD – Brigham and Women's Hospital/Dana-Farber

  • 5:05 PM – 5:10 PM PT
    1072 - PD-L1 Inhibitors Combined with Thoracic Radiotherapy in First-Line Treatment of Extensive Stage Small Cell Lung Cancer: A Propensity Score-Matched, Real-World Study
    Location: Room 8

    Presenter: Jianfeng Peng, PhD

  • 5:10 PM – 5:15 PM PT
    1074 - Progression-Free Survival As a Surrogate Endpoint of Overall Survival in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy: Trial-Level Meta-Analysis and Individ
    Location: Room 8

    Presenter: Chen Hu, PhD – Johns Hopkins University

  • 5:15 PM – 5:20 PM PT
    1076 - Early Stereotactic Body Radiotherapy to the Primary Lung Lesion for Patients with Advanced NSCLC Treated with First-Line Systemic Therapy
    Location: Room 8

    Presenter: Dan Tao, MD – Chongqing University Cancer Hospital

  • 5:20 PM – 5:25 PM PT
    1078 - Treatment Efficacy Outcomes Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Survival Analysis of a Phase IB trial
    Location: Room 8

    Presenter: Brett Morris, MD, PhD – University of Wisconsin

  • 5:25 PM – 5:30 PM PT
    1080 - Genomic Signature for Oligometastatic Disease in Non-Small Cell Lung Cancer Patients with Brain Metastases
    Location: Room 8

    Presenter: Ariel Choi, MD – Wake Forest Baptist Medical Center

  • 5:00 PM – 6:00 PM PT
    2599 - Determining the Minimal Clinically Important Difference of the FACT-E to Evaluate the Change in the Quality of Life of Patients with Esophageal Cancer Treated with Curative Radiotherapy
    Location: Hall B1

    Presenter: Isabella Zaniletti, PhD – IZ Statistics LLC

  • Tuesday, October 3, 2023
  • 8:00 AM – 8:07 AM PT
    213 - Polymetastatic Recurrence-Free Survival in Patients with Repeat Oligometastases on the SABR-5 Trial
    Location: Room 4

    Presenter: Wei Liu, MD – BC Cancer - Vancouver Centre

  • 8:10 AM – 8:17 AM PT
    214 - Multi-Institutional Validation of the Recursive Partitioning Analysis for Overall Survival in Patients Undergoing Spine Radiosurgery for Spine Metastasis
    Location: Room 4

    Presenter: Sami Koro, MD – University of Iowa Hospitals and Clinics

  • 8:20 AM – 8:27 AM PT
    215 - Predictors of Hepatotoxicity in Patients with Metastatic Solid Tumors Treated with Immune Checkpoint Inhibition (ICI) and Liver-Directed SBRT
    Location: Room 4

    Presenter: Connor Lynch, MD – University of Chicago

  • 8:30 AM – 8:37 AM PT
    216 - Prompt Pain Relief: Advanced Practice Provider Led Rapid Access Palliative Radiotherapy Clinic
    Location: Room 4

    Presenter: Michelle Wear, MSN – Mayo Clinic Florida

  • 8:40 AM – 8:47 AM PT
    217 - Provider Perceptions of a Novel Inpatient Co-Rounding Model Integrating Medical Oncology, Neuro-Oncology, and Radiation Oncology for the Care of Patients with Advanced Cancer
    Location: Room 4

    Presenter: Lisa Ni, MD – University of California San Francisco

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 4

    Discussant: Lauren Hertan, MD, MS – Beth Israel Deaconess Medical Center

  • 8:00 AM – 8:07 AM PT
    208 - 30 Gy vs. 45 Gy Consolidative Thoracic Radiation (cTRT) for Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Multicenter, Randomized, Phase 3 Trial
    Location: Room 6 C/F

    Presenter: Nan Bi, MD, PhD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

  • 8:10 AM – 8:17 AM PT
    209 - Thoracic Radiotherapy Improves the Outcomes of Extensive Stage Small-Cell Lung Cancer Patients Receiving First-Line Immunotherapy: A Multicenter Retrospective Analysis
    Location: Room 6 C/F

    Presenter: Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute

  • 8:20 AM – 8:27 AM PT
    210 - A Multicentered, Randomized Phase ? Study of Definitive vs. Palliative Radiotherapy to Primary Tumor for Stage ? Non-Small Cell Lung Cancer with Less than Three Metastatic Organs: CSWOG China
    Location: Room 6 C/F

    Presenter: Geng Yichao, MD – The Affiliated Hospital of Guizhou Medical University

  • 8:30 AM – 8:37 AM PT
    211 - Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II STOP Trial
    Location: Room 6 C/F

    Presenter: Devin Schellenberg, MD, BS – BC Cancer - Vancouver Centre

  • 8:40 AM – 8:45 AM PT
    212 - Safety and Efficacy Analysis of Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated with SHR-1316 Plus Chemotherapy and Sequential Chest Radiotherapy as First-Line Therapy from a Ph
    Location: Room 6 C/F

    Presenter: Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute

  • 8:48 AM – 8:58 AM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Dawn Owen, MD, PhD – Mayo Clinic Rochester

  • 8:00 AM – 8:07 AM PT
    202 - Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with Chemoradiotherapy
    Location: Room 2

    Presenter: Sang Ho Lee, PhD – University of Pennsylvania

  • 8:10 AM – 8:17 AM PT
    203 - Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation Therapy
    Location: Room 2

    Presenter: Christian Guthier, PhD, MS – Brigham and Womens Hopsital

  • 8:20 AM – 8:27 AM PT
    204 - Dynamic Prediction of Toxicities in Head and Neck Cancer Radiotherapy by 3D Convolutional Neural Network Using Daily Cone-Beam CTs
    Location: Room 2

    Presenter: Chulmin Bang, MD – Centre Hospitalier de l'Universite de Montreal (CHUM)

  • 8:30 AM – 8:37 AM PT
    205 - Deep Learning for Automatic Prediction of Lymph Node Station Metastasis in Esophageal Cancer Patients from Contrast-Enhanced CT
    Location: Room 2

    Presenter: Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute

  • 8:40 AM – 8:47 AM PT
    206 - Machine Parameter Optimization of a Clinical Linear Accelerator Using Deep Reinforcement Learning for Automatic Generation of Deliverable Prostate VMAT Plans
    Location: Room 2

    Presenter: William Hrinivich, PhD – Johns Hopkins University

  • 8:50 AM – 8:57 AM PT
    207 - Clinico-Genomics Model to Predict Survival in Non-Metastatic Breast Cancer: Comparing the Performance of Machine Learning Models
    Location: Room 2

    Presenter: Adrianna Cueto-Marquez, MD, BS – Rush University Medical Center

  • 8:05 AM – 8:10 AM PT
    1278 - Real-Time 3D Liver Tumor Localization via Combined Optical Surface Imaging and an X-Ray Projection from Arbitrary Imaging Angles
    Location: Room 8

    Presenter: Hua-Chieh Shao, PhD – University of Texas Southwestern Medical Center

  • 8:10 AM – 8:15 AM PT
    1280 - Development of a Filtimator for Pediatric Image-Guided Radiation Therapy with Low Imaging Dose
    Location: Room 8

    Presenter: Soon Huh, PhD – University of Florida Proton Therapy Institute

  • 8:15 AM – 8:20 AM PT
    1282 - Real Time 4D-Cone Beam CT via Single-Angle Projection with Dual Attention Mechanism
    Location: Room 8

    Presenter: Jun Dang, PhD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

  • 8:20 AM – 8:25 AM PT
    1284 - SEA-Net: Structure-Enhanced Attention Network for Limited-Angle CBCT Reconstruction of Clinical Projection Data
    Location: Room 8

    Presenter: Hao Gao, PhD – University of Kansas Medical Center

  • 8:25 AM – 8:30 AM PT
    1286 - Rapid Unpaired CBCT-based Synthetic CT for CBCT-guided Adaptive Radiotherapy
    Location: Room 8

    Presenter: Jacob Wynne, MD – Emory University School of Medicine

  • 8:30 AM – 8:35 AM PT
    1288 - Liver Dome Gating Using kV Triggered Imaging Reduces Dosimetric Error Caused by Breath Hold Variability for Liver Stereotactic Body Radiation Therapy
    Location: Room 8

    Presenter: Bingqi Guo, PhD – Cleveland Clinic Taussig Cancer Center

  • 12:50 PM – 12:55 PM PT
    1084 - Bacterial Composition and Diversity in the Cervical Tumor Microbiome are Closely Associated with HPV Genotype in a Large, International Patient Cohort
    Location: Room 7

    Presenter: Molly El Alam, MPH – MD Anderson Cancer Center

  • 12:55 PM – 1:00 PM PT
    1086 - Postoperative Radiotherapy to Abdominal and Pelvic Lymphatic Drainage Area for Stage III Epithelial Ovarian Cancer: A Sharp Tool to Prolong Disease-Free Survival Time
    Location: Room 7

    Presenter: Jing Shen, MD – Chinese Academy of Medical Sciences and Peking Union Medical College

  • 1:00 PM – 1:05 PM PT
    1088 - Genomic Characterization of Cervical Tumors Driven by Rare High-Risk HPV Subtypes Utilizing a Deep Learning Framework
    Location: Room 7

    Presenter: Michael Waters, MD, PhD – Washington University St. Louis

  • 1:10 PM – 1:15 PM PT
    1092 - Machine-Learning Model of Pre-Treatment MRI Accurately Predicts Progression Following Cervical Cancer Radiotherapy
    Location: Room 7

    Presenter: Jeffrey Wang, BS – George Washington University School of Medicine

  • 1:15 PM – 1:22 PM PT
    1094 - The Prognostic Impact of Substantial Lymphovascular Space Invasion in Women with FIGO Stage I Uterine Endometrioid Carcinoma with Pathologically Negative Nodal Evaluation
    Location: Room 7

    Presenter: Aseem Bhatnagar, MD – Henry Ford Hospital

  • 12:45 PM – 12:52 PM PT
    224 - Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging (MRI) for Assessment of Treatment Response in Unresectable Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
    Location: Room 29

    Presenter: Lucas McCullum, BS – MD Anderson Cancer Center

  • 12:55 PM – 1:02 PM PT
    225 - Differential Response in Quantitative MRI Parameters Detected in Head and Neck Cancer Patients Treated with Concurrent Immunotherapy during Hypo-Fractionated MR-gRT
    Location: Room 29

    Presenter: Ryan Bonate, BS – Medical College of Wisconsin

  • 1:05 PM – 1:12 PM PT
    226 - Pattern Analysis of Daily Lesion Volume Trajectories for Early Prediction of Glioblastoma Progression During MR-Linac Radiotherapy
    Location: Room 29

    Presenter: Kaylie Cullison, BS – University of Miami Sylvester Comprehensive Cancer Center

  • 1:15 PM – 1:22 PM PT
    227 - Fraction Size, Total Dose and Respiratory Control Impact Local Control in Adrenal SBRT
    Location: Room 29

    Presenter: Ory Haisraely, MD, MPH – Tel Hashomer Hospital

  • 1:25 PM – 1:32 PM PT
    228 - Tumor Voxel Dose-Response Matrix Prediction Using Deep Learning
    Location: Room 29

    Presenter: Shupeng Chen, PhD – Corewell Health William Beaumont University Hospital

  • 1:35 PM – 1:42 PM PT
    229 - Image Derived Estimates of Fibrosis Using Ultrashort Echo Time MRI in Gynecologic Cancer
    Location: Room 29

    Presenter: Khadija Sheikh, PhD, MS – Johns Hopkins University School of Medicine

  • 1:45 PM – 1:52 PM PT
    230 - Comprehensive Quality of Life Report from a Prospective Clinical Trial of 4DCT-Ventilation Functional Lung Avoidance Radiation Therapy
    Location: Room 29

    Presenter: Joseph Lombardo, DO – MD Anderson Cancer Center at Cooper

  • 12:45 PM – 12:52 PM PT
    218 - Management and Outcomes of Hodgkin Lymphoma Patients Who Achieve Partial Metabolic Response on PET Scans Post-Chemotherapy
    Location: Room 1

    Presenter: Donna Liao, MD – University of Toronto

  • 12:55 PM – 1:02 PM PT
    219 - Quality Analysis of Radiation Therapy for Hodgkin Lymphoma in the HD 16/17 Trials: A Final Report By the Reference Radiation Oncology Panel of the German Hodgkin Study Group
    Location: Room 1

    Presenter: Michael Oertel, MD – University Hospital of Muenster

  • 1:05 PM – 1:12 PM PT
    220 - Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma Study
    Location: Room 1

    Presenter: Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida

  • 1:15 PM – 1:22 PM PT
    221 - Radiotherapy in Young, High-Risk Patients with Aggressive B-cell Lymphoma: Long-Term Results from the Open-Label, Randomized, Phase 3 R-MegaCHOEP Trial
    Location: Room 1

    Presenter: Michael Oertel, MD – University Hospital of Muenster

  • 1:25 PM – 1:32 PM PT
    222 - Association of Overall Survival Benefit Profile of Radiotherapy with Progression-Free Survival after Chemotherapy for Diffuse Large B-Cell Lymphoma
    Location: Room 1

    Presenter: Jingnan Wang, MD – Cancer Hospital Chinese Academy of Medical Sciences

  • 1:35 PM – 1:42 PM PT
    223 - Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients
    Location: Room 1

    Presenter: Beatrice Fregonese, MPH – Memorial Sloan Kettering Cancer Center

  • 1:45 PM – 1:55 PM PT
    Discussant
    Location: Room 1

    Discussant: Richard Hoppe, MD, FASTRO – Stanford University

  • 12:50 PM – 12:55 PM PT
    1096 - Impact of Consolidative Radiation on Overall and Progression Free Survival in Pediatric, Adolescent and Young Adult Metastatic Sarcoma
    Location: Room 8

    Presenter: Leslie Chang, MD – Johns Hopkins University

  • 12:55 PM – 1:00 PM PT
    1098 - The Role of Whole Abdomen and Pelvis Radiation Therapy in Desmoplastic Small Round Cell Tumor
    Location: Room 8

    Presenter: Michael Young, MD – UNC Hospitals

  • 1:00 PM – 1:05 PM PT
    1100 - Association between Radiation Dose and Local Failure in Recurrent High-Risk Neuroblastoma
    Location: Room 8

    Presenter: Christopher Weil, MD, MS – MD Anderson Cancer Center

  • 1:05 PM – 1:10 PM PT
    1102 - Proton Therapy Mediates Dose Reductions to Critical Brain Organs-at-Risk which are Associated with Better Cognition in Children with Medulloblastoma
    Location: Room 8

    Presenter: Julianna Sienna, MD, MS – Juravinski Cancer Centre

  • 1:10 PM – 1:15 PM PT
    1104 - Memantine for Pediatric Patients Receiving Cranial Irradiation: A Pilot Study
    Location: Room 8

    Presenter: Elizabeth McKone, MD – Mayo Clinic Rochester

  • 1:15 PM – 1:20 PM PT
    1106 - Pancreas: An Organ-at-Risk to Consider in Future Pediatric Abdominal Radiotherapy
    Location: Room 8

    Presenter: Sabrina Taylor, BS – University College London

  • 2:30 PM – 2:37 PM PT
    231 - Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials
    Location: Room 1

    Presenter: Zaid Iftekaruddin, MD – University of Chicago Medicine

  • 2:40 PM – 2:47 PM PT
    232 - A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive Chemoradiation
    Location: Room 1

    Presenter: Joseph Kim, MD – NYU Langone Medical Center

  • 2:50 PM – 2:57 PM PT
    233 - Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016
    Location: Room 1

    Presenter: Loren Mell, MD, FASTRO – University of California, San Diego

  • 2:50 PM – 2:57 PM PT
    233 - Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016
    Location: Room 1

    Presenter: Ryan Morse, MD – University of North Carolina at Chapel Hill

  • 3:00 PM – 3:07 PM PT
    234 - Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the PRO-NPC-001 Cluster-Randomized Trial
    Location: Room 1

    Presenter: Jacob Miller, MD – Cleveland Clinic Foundation

  • 3:10 PM – 3:17 PM PT
    235 - Prospective Efficacy of Two Cycles Toripalimab Plus Induction Chemotherapy in T4 or N3 Locoregionally Advanced Nasopharyngeal Carcinoma: A Retrospective and Mechanistic Study
    Location: Room 1

    Presenter: Fengming Lan, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

  • 3:20 PM – 3:30 PM PT
    Discussant
    Location: Room 1

    Discussant: Annie Chan, MD – Massachusetts General Hospital

  • 2:35 PM – 2:40 PM PT
    1108 - The Presence of Extensive Lymphovascular Invasion (LVI) is Associated with Higher Risk of Recurrence in Curatively Treated Breast Cancer Patients
    Location: Room 7

    Presenter: Olufela Koleoso, MS, BS – Philadelphia College of Osteopathic Medicine

  • 2:40 PM – 2:45 PM PT
    1110 - 5-Year Results from a Prospective Phase II Trial of Ten-Fractions Hypofractionated Radiotherapy in Locally Advanced Breast Cancer
    Location: Room 7

    Presenter: Silvia Takanen, MD – Regina Elena National Cancer Institute

  • 2:45 PM – 2:50 PM PT
    1112 - Addition of Metastasis-Directed Therapy to Standard of Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
    Location: Room 7

    Presenter: Jay Paul Reddy, MD, PhD – MD Anderson Cancer Center

  • 2:50 PM – 2:55 PM PT
    1114 - First Results of the Primary Outcome of a Phase II Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Breast Cancer Patients
    Location: Room 7

    Presenter: Zeinab Abou Yehia, MD – Associates in Radiation Medicine-ARM Oncology

  • 2:55 PM – 3:00 PM PT
    1116 - Single-Fraction Pre-Operative Stereotactic Radiosurgery for Early-Stage Breast Cancer: Pathological Findings
    Location: Room 7

    Presenter: Marco Trovo

  • 3:00 PM – 3:05 PM PT
    1118 - Factors Associated with Cardiac Radiation Dose Reduction Following Hypofractionated Radiation Therapy for Localized, Left-Sided Breast Cancer in a Large Statewide Quality Consortium
    Location: Room 7

    Presenter: Daniel Herr, MD, PhD – University of Michigan

  • 2:33 PM – 2:40 PM PT
    243 - Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain Metastases
    Location: Room 6 C/F

    Presenter: Kailin Yang, MD, PhD – Cleveland Clinic Taussig Cancer Center

  • 2:43 PM – 2:50 PM PT
    244 - Radiotherapy for Metastatic Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial
    Location: Room 6 C/F

    Presenter: Dirk Rades, MD, FASTRO – University of Luebeck

  • 2:53 PM – 3:00 PM PT
    245 - Results of a Multi-institutional Randomized Phase 3 Trial of Parotid-Sparing Whole Brain Radiotherapy
    Location: Room 6 C/F

    Presenter: Kyle Wang, MD – University of Cincinnati

  • 3:03 PM – 3:10 PM PT
    246 - Evidence-Based Multivariate Normal Tissue Complication Probability (NTCP) Study of Domain-Specific Cognitive Decline after Partial Brain RT
    Location: Room 6 C/F

    Presenter: Austin Hopper, MD – UCSD Radiation Medicine and Applied Sciences

  • 3:13 PM – 3:20 PM PT
    247 - Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain Metastases
    Location: Room 6 C/F

    Presenter: Nayan Lamba, MD – Harvard Radiation Oncology Program

  • 3:23 PM – 3:28 PM PT
    1262 - Stereotactic Radiotherapy or Whole Brain Radiotherapy Combined with Pyrotinib and Capecitabine in HER2-Positive Advanced Breast Cancer Patients with Brain Metastases (BROPTIMA): A Prospective, Phase I
    Location: Room 6 C/F

    Presenter: Wei Shi, MD, PhD – Fudan University Shanghai Cancer Center

  • 3:28 PM – 3:38 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Stuart Burri, MD – Levine Cancer Institute

  • 2:30 PM – 2:37 PM PT
    236 - Neoantigen Cancer Vaccine Improves the Therapeutic Efficacy of Radiotherapy in Immunologically Cold Microsatellite-Stable Colorectal Cancer
    Location: Room 2

    Presenter: K. S. Clifford Chao, MD – China Medical University Hospital

  • 2:40 PM – 2:47 PM PT
    237 - Non-Redundant Mechanisms of Immune Resistance to Radiotherapy Converge on Innate Immunity
    Location: Room 2

    Presenter: Anthony Nguyen, MD, PhD – Cedars-Sinai Medical Center

  • 2:50 PM – 2:57 PM PT
    238 - The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell Chemokines
    Location: Room 2

    Presenter: Benjamin Lok, MD – Princess Margaret Cancer Centre

  • 2:50 PM – 2:57 PM PT
    238 - The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell Chemokines

    Presenter: Xiaozhuo Ran, PhD – University Health Network

  • 3:00 PM – 3:07 PM PT
    239 - Radiotherapy Shows Synergistic Anti-Tumor Efficacy with Treg Depletion by Reprogramming the Immune-Excluded Tumor Microenvironment
    Location: Room 2

    Presenter: Sophia Pfister, PhD – Varian Medical Systems, A Siemens Healthineers Company

  • 3:10 PM – 3:17 PM PT
    240 - Blocking ILT4 Overcomes Radio-Immunotherapy Treatment Resistance by Reversing HFRT Induced CXCL1-CXCR2 Axis Activation and Tumor-Associated Macrophages Immunosuppression
    Location: Room 2

    Presenter: Xiaozheng Chen, PhD

  • 3:30 PM – 3:40 PM PT
    Discussant
    Location: Room 2

    Discussant: Zachary Morris, MD, PhD – University of Wisconsin Hospitals and Clinics

  • 2:30 PM – 3:45 PM PT
    2972 - Diagnostic Performance of 18F-rhPSMA-7.3 PET in Men with Newly Diagnosed High-Risk Prostate Cancer and Negative Conventional Imaging
    Location: Hall B1

    Presenter: Gary Ulaner, MD, PhD

  • 2:30 PM – 2:40 PM PT
    LBA 08 - Acute Toxicity and Efficiency Outcomes in the DARTBOARD Randomized Trial of Daily Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma
    Location: Room 6 B

    Presenter: David Sher, MD, MPH – University of Texas Southwestern Medical Center

  • 2:40 PM – 2:50 PM PT
    LBA 09 - Stereotactic Ablative Body Radiotherapy (SABR) for Oligoprogressive ER-Positive Breast Cancer (AVATAR): A Phase II Prospective Multicenter Trial
    Location: Room 6 B

    Presenter: Steven David, MD, MBBS – Peter MacCallum Cancer Centre

  • 2:50 PM – 3:00 PM PT
    LBA 10 - Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003)
    Location: Room 6 B

    Presenter: Anna Kirby, MD – Royal Marsden NHS Foundation Trust

  • 3:00 PM – 3:10 PM PT
    LBA 11 - Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer
    Location: Room 6 B

    Presenter: Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center

  • 3:10 PM – 3:20 PM PT
    LBA 12 - Stereotactic Radiosurgery for 1-10 Brain Metastases avoids Whole-Brain Radiotherapy - Results of the CYBER-SPACE Randomized Phase 2 Trial
    Location: Room 6 B

    Presenter: Rami El Shafie, MD – University Medical Center Gottingen (UMG)

  • 3:20 PM – 3:30 PM PT
    LBA 13 - Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity versus Whole-Brain Radiotherapy (WBRT) following Brain Metastasis Resection - Results of the ESTRON Randomized Phase 2 Trial
    Location: Room 6 B

    Presenter: Rami El Shafie, MD – University Medical Center Gottingen (UMG)

  • 3:30 PM – 3:40 PM PT
    LBA 14 - Diagnostic CT-Enabled Radiation Therapy (DART): Results of a Randomized Trial for Palliative Radiation Therapy
    Location: Room 6 B

    Presenter: Melissa O'Neil, MRT(T) – London Regional Cancer Program

  • 4:00 PM – 4:07 PM PT
    248 - Outcomes Following Radiation Therapy (RT) for Very Young Age CNS Embryonal Tumors on COG ACNS0334 According to Molecular-Confirmed Diagnosis
    Location: Room 2

    Presenter: Katherine Schumacher, MD – SUNY Upstate Radiation Oncology

  • 4:10 PM – 4:17 PM PT
    249 - Long Term Clinical Outcome and Quality of Life of Children, Adolescents and Young Adults Treated with Pencil Beam Scanning Proton Therapy for Rhabdomyosarcoma
    Location: Room 2

    Presenter: Dominic Leiser, MD – Paul Scherrer Institute

  • 4:20 PM – 4:27 PM PT
    250 - High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single Institution
    Location: Room 2

    Presenter: Kaitlyn Lapen, MD – Memorial Sloan Kettering Cancer Center

  • 4:30 PM – 4:37 PM PT
    251 - Dose-Effect of Proton and Photon Craniospinal Irradiation on Vertebral Growth in Pediatric Patients with Medulloblastoma
    Location: Room 2

    Presenter: Carol Oliveira, MD, PhD – St. Jude Children's Research Hospital

  • 4:40 PM – 4:47 PM PT
    252 - Intraoperative Radiation Therapy for Pediatric Patients: A 25 Year Experience
    Location: Room 2

    Presenter: Brianna Conte, BS – University of Miami Miller School of Medicine

  • 4:50 PM – 5:00 PM PT
    Discussant
    Location: Room 2

    Discussant: Susan Hiniker, MD – Stanford University

  • 4:05 PM – 4:10 PM PT
    1132 - Proton Single-Energy Bragg-Peak FLASH Using Clinical Systems Can Achieve IMPT-Equivalent Plan Quality for Breast and Prostate Cancers
    Location: Room 7

    Presenter: Tyler Kaulfers, BS – Hofstra University

  • 4:10 PM – 4:15 PM PT
    1134 - Initial Experience with the Commercial Electron FLASH Research Extension
    Location: Room 7

    Presenter: Kyle Gallagher, PhD – University of Nebraska Medical Center

  • 4:15 PM – 4:20 PM PT
    1136 - 3D Dosimetry for Electron Flash Radiotherapy: Assessment of Radiochromic Dosimeter Phantoms with Optical CT Scanning as a 3D Dosimetry System
    Location: Room 7

    Presenter: Carl Elliston, MS, DABR – Columbia University Irving Medical Center

  • 4:20 PM – 4:25 PM PT
    1138 - Proton LET Optimization Via Iterative Convex Relaxation Method
    Location: Room 7

    Presenter: Wangyao Li, PhD – University of Kansas Medical Center

  • 4:25 PM – 4:30 PM PT
    1140 - Clinical Characterization of a Novel Robotic IORT Unit
    Location: Room 7

    Presenter: Thomas Niedermayer, PhD – Stanford Advanced Medicine Center

  • 4:30 PM – 4:35 PM PT
    1142 - Efficacy of Curvilinear Needle Implantation for Prostate HDR Brachytherapy
    Location: Room 7

    Presenter: Rihan Podder, BS – University of Florida

  • 4:05 PM – 4:10 PM PT
    1120 - Sema3C Signaling is an Alternative Activator of the Canonical WNT Pathway in Glioblastoma
    Location: Room 8

    Presenter: Jennifer Yu, MD, PhD – Cleveland Clinic Taussig Cancer Center

  • 4:10 PM – 4:15 PM PT
    1122 - Tumor Resistance to Fractionated Radiotherapy in Obese Mice
    Location: Room 8

    Presenter: Logan Vick, BA – University of California, Davis

  • 4:15 PM – 4:20 PM PT
    1124 - IKBKE Promotes Radioresistance of Glioblastoma through AKT/FOXO3a Pathway
    Location: Room 8

    Presenter: Jie Lu, PhD

  • 4:20 PM – 4:25 PM PT
    1126 - RAP80 Phase Separation at DNA Double-Strand Break Promotes BRCA1 Recruitment and Tumor Radio-Resistance
    Location: Room 8

    Presenter: Xinjuan Fan, MD, PhD – Sixth Affiliated Hospital, Sun Yat-sen University

  • 4:25 PM – 4:30 PM PT
    1128 - Mitotic Errors Increase Radiation Sensitivity in Multiple Cancer Cell Types and in Laryngeal Cancer Patients
    Location: Room 8

    Presenter: Pippa Cosper, MD, PhD – University of Wisconsin

  • 4:30 PM – 4:35 PM PT
    1130 - Novel Role of Glycogen Synthase Kinase-3ß in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 Function
    Location: Room 8

    Presenter: Scarlett Acklin, MD – Duke University

  • 4:05 PM – 4:10 PM PT
    1144 - Leveraging a Real-Time Machine Learning Platform to Personalize Quality Assurance at a Large Multi-Site Oncology Practice
    Location: Room 4

    Presenter: William Lindsay, MD, PhD – Oncora Medical LLC

  • 4:10 PM – 4:15 PM PT
    1146 - Natural Language Processing Identification of Symptoms in Emergency Department Visits in Patients Receiving Radiation
    Location: Room 4

    Presenter: Alexander Qian, MD – University of California San Francisco

  • 4:15 PM – 4:20 PM PT
    1148 - Clinical Usability-Oriented Automatic Contour Quality Evaluation for Deep Learning Auto-Segmentation
    Location: Room 4

    Presenter: Ying Zhang, PhD – Medical College of Wisconsin

  • 4:20 PM – 4:25 PM PT
    1150 - Mitigation of IMRT/SBRT Treatment Planning Errors on the First Biology-Guided Radiotherapy System Using FMEA within Six Sigma Framework
    Location: Room 4

    Presenter: Eric Simiele, PhD – University of Alabama at Birmingham

  • 4:25 PM – 4:30 PM PT
    1152 - Quality and Safety Considerations in Image Guided Radiation Therapy: An ASTRO Safety White Paper Update
    Location: Room 4

    Presenter: Terence Sio, MD, MS – Mayo Clinic

  • 4:30 PM – 4:35 PM PT
    1154 - Assessing the Sustainability of Initiatives Aimed to Enhance Patient Safety Culture: A > 10-year Experience with Multifaceted Interventions
    Location: Room 4

    Presenter: Ashley Weiner, MD, PhD – UNC School of Medicine

  • 4:05 PM – 4:10 PM PT
    1156 - Meta-Analysis of Five Fraction Preoperative Radiotherapy for Soft Tissue Sarcoma
    Location: Room 5

    Presenter: Zachary Mayo, MD – Cleveland Clinic Foundation

  • 4:10 PM – 4:15 PM PT
    1158 - Initial Results of a Phase II Trial of Hypofractionated Radiation Therapy for Inoperable Soft Tissue Sarcoma
    Location: Room 5

    Presenter: Bradley Eckelmann, MD, PhD – University of Wisconsin Hospitals and Clinics

  • 4:15 PM – 4:20 PM PT
    1160 - Hypofractionated Accelerated Radiation Dose-Painting (HARD) Improves Local Control in Unresected Soft-Tissue Sarcoma
    Location: Room 5

    Presenter: John Michael Bryant, MD – Moffitt Cancer Center

  • 4:20 PM – 4:25 PM PT
    1162 - Pre-Operative Radiotherapy in STS: Does Downsizing Matter?
    Location: Room 5

    Presenter: Paulina Gutkin, BS – Medical College of Wisconsin Froedtert Hospital

  • 4:25 PM – 4:30 PM PT
    1164 - Dawn of Staging for Head and Neck Soft Tissue Sarcoma: Validation of the Novel 8th Edition AJCC T Classification and Proposed Stage Groupings
    Location: Room 5

    Presenter: Rohan Salunkhe, MD, MBBS – Princess Margaret Cancer Center, University Health Network

  • 4:30 PM – 4:35 PM PT
    1166 - Outcomes for Patients with Head and Neck Sarcoma Treated Curatively with Radiation Therapy and Surgery
    Location: Room 5

    Presenter: Alison Yoder, MD, MPH – MD Anderson Cancer Center

  • 4:35 PM – 4:40 PM PT
    1168 - Patterns of local recurrence and risk of skin recurrence in soft tissue sarcomas after surgical resection.
    Location: Room 5

    Presenter: Agnes Ewongwo, MD – Stanford University

  • 4:00 PM – 5:00 PM PT
    Hypofractionated Radiotherapy for Hematological Malignancies during COVID-19 Pandemic and Beyond

    Presenter: Febin Antony, MD, MBBS – Amala Institute of Medical Sciences, Thrissur

  • 4:00 PM – 5:00 PM PT
    2992 - Development of Population-Based Pediatric Computational Phantoms for Radiotherapy Applications
    Location: Hall B1

    Presenter: Reem Ahmad, PhD – University College London

  • 5:15 PM – 5:22 PM PT
    259 - FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (
    Location: Room 6 B

    Presenter: Paul Nguyen, MD, FASTRO – Brigham and Women's Hospital/Dana-Farber

  • 5:25 PM – 5:32 PM PT
    260 - Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)
    Location: Room 6 B

    Presenter: Anand Swaminath, MD – Juravinski Cancer Centre

  • 5:35 PM – 5:42 PM PT
    261 - Impact of Testosterone Recovery on Clinical Outcomes of Patients Treated with Salvage Radiotherapy and Androgen Suppression: A Secondary Analysis of the NRG/RTOG 0534 Spport Phase 3 Trial
    Location: Room 6 B

    Presenter: Alan Dal Pra, MD – University of Miami - Sylvester Cancer Center

  • 5:45 PM – 5:52 PM PT
    262 - Post-Prostatectomy Risk Stratification of Biochemical Recurrence Using Transfer Learning-Based Multi-Modal Artificial Intelligence
    Location: Room 6 B

    Presenter: Atallah Baydoun, MD, PhD – Case Western Reserve University

  • 5:55 PM – 6:02 PM PT
    263 - 5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK)
    Location: Room 6 B

    Presenter: Vivian Tan, MD – London Health Sciences Centre

  • 6:05 PM – 6:15 PM PT
    Discussant
    Location: Room 6 B

    Discussant: William Hall, MD – Medical College of Wisconsin (MCW)

  • 5:15 PM – 5:22 PM PT
    253 - Impact of War on Radiotherapy in Ukraine
    Location: Room 2

    Presenter: Yuliia Lozko, MD – Stanford Cancer Institute Palo Alto

  • 5:25 PM – 5:32 PM PT
    254 - Radiotherapy Resources in Latin America and the Caribbean: An International Atomic Energy Agency Analysis of Current and Projected Needs
    Location: Room 2

    Presenter: May Elbanna, MD, PhD – Indiana University

  • 5:35 PM – 5:42 PM PT
    255 - Timely Access to Oncological Treatment in Brazil: Analysis of the 60-Law Compliance in a State Database
    Location: Room 2

    Presenter: Cecília de Sousa, MD – Johns Hopkins School of Public Health

  • 5:45 PM – 5:52 PM PT
    256 - Impact of AI-Based Auto-Segmentation on Radiotherapy Processes in Low and Middle-Income Countries
    Location: Room 2

    Presenter: Solomon Kibudde, MBBS – Uganda Cancer Institute

  • 5:55 PM – 6:02 PM PT
    257 - SCCAg as a Biomarker of Advanced Stage and OS in Limited Resource Setting for Cervical Cancer
    Location: Room 2

    Presenter: Rohini Bhatia, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center

  • 6:05 PM – 6:12 PM PT
    258 - Cobalt Compensator-Based IMRT for Gynecologic Cancer Treatment in Low- and Middle-Income Countries: Equivalence to LINAC-Based IMRT
    Location: Room 2

    Presenter: Peter Zaki, MD – University of Washington

  • 5:20 PM – 5:25 PM PT
    1194 - Influence of Radiation Fractionation on Immune Repertoire Diversity in Solid Tumor Patients
    Location: Room 8

    Presenter: Susannah Ellsworth, MD – University of Pittsburgh Medical Center

  • 5:25 PM – 5:30 PM PT
    1196 - Single-Cell and Spatial Transcriptomics Revealing the Role of IDO1 in HPV+ Cervical Cancer Tumor Immune Microenvironment and Its Implications in Radiotherapy and Immunotherapy
    Location: Room 8

    Presenter: Zheng Danyang, MD, PhD, MS – The University of Hong Kong

  • 5:35 PM – 5:40 PM PT
    1200 - Characterization of Peripheral T-Cell Dynamics in the Patients with Bone Metastasis from Breast Cancer Following Stereotactic Body Radiotherapy
    Location: Room 8

    Presenter: In Ah Kim, MD, PhD – Seoul National University

  • 5:40 PM – 5:45 PM PT
    1202 - PARP Inhibitor Plus Radiotherapy Reshapes IDH1 Mutation Tumor Immune Suppression Microenvironment Potentiating the Efficiency of Immune Checkpoint Inhibitor
    Location: Room 8

    Presenter: Xiaoyu Hu, MD, PhD – Shandong Cancer Hospital and Institute

  • 5:45 PM – 5:50 PM PT
    1204 - Loss of MAPKAPK2 Enhances cGAS-STING-IFNß1 Pathway Activation in Head and Neck Squamous Cell Carcinoma
    Location: Room 8

    Presenter: Deri Morgan, PhD – KUMC

  • 5:20 PM – 5:25 PM PT
    1182 - Automatic Prediction of Metastasis-Free Survival (MFS) Using Prostate-Specific Membrane Antigen (PSMA) PET for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC)
    Location: Room 7

    Presenter: Yufeng Cao, PhD – University of Maryland Central Maryland Radiation Oncology

  • 5:25 PM – 5:30 PM PT
    1184 - A Dosimetric Study Indicates the Spinal Cord Irradiation Contributes to Acute Hematologic Toxicities in Non-Small Cell Lung Cancer Patients Receiving Radiotherapy Combined with Immunotherapy
    Location: Room 7

    Presenter: Jiachun Ma – Shandong Cancer Hospital and Institute

  • 5:30 PM – 5:35 PM PT
    1186 - Novel Functional Radiomics for Prediction of Cardiac PET Avidity in Lung Cancer Radiotherapy
    Location: Room 7

    Presenter: Wookjin Choi, PhD – Thomas Jefferson University

  • 5:35 PM – 5:40 PM PT
    1188 - Prognostic Value of Weekly Delta-Radiomics during MR-Linac Radiotherapy of Glioblastoma
    Location: Room 7

    Presenter: Kaylie Cullison, BS – University of Miami Sylvester Comprehensive Cancer Center

  • 5:40 PM – 5:45 PM PT
    1190 - A Radiogenomic Machine Learning Model for Glioblastoma Post-Resection Overall Survival Group Prediction
    Location: Room 7

    Presenter: Lana Wang, MS – Duke University

  • 5:45 PM – 5:50 PM PT
    1192 - Prediction of Anatomical Presentation during Radiotherapy of Nasopharyngeal Carcinoma Using GAN-LSTM for Plan Adaption Decision
    Location: Room 7

    Presenter: Bining Yang, PhD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy

  • 5:20 PM – 5:25 PM PT
    1170 - Definitive Chemoradiation Treatment Response Evaluation Using NI-RADS and ctHPVDNA for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Location: Room 4

    Presenter: Ryan Morse, MD – University of North Carolina at Chapel Hill

  • 5:25 PM – 5:30 PM PT
    1172 - The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer in NRG/RTOG 1016
    Location: Room 4

    Presenter: Joanne Weidhaas, MD, PhD – UCLA Radiation Oncology

  • 5:30 PM – 5:35 PM PT
    1174 - Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer
    Location: Room 4

    Presenter: Daniel Huang, MD – University of Chicago

  • 5:35 PM – 5:40 PM PT
    1176 - A Pilot, First in Human Study of Autologous IFN-Gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-Induced Xerostomia
    Location: Room 4

    Presenter: Grace Blitzer, MD – University of Wisconsin

  • 5:40 PM – 5:45 PM PT
    1178 - Delta-Radiomics Guides Adaptive De-Intensification after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma in the IMRT Era
    Location: Room 4

    Presenter: Shun-Xin Wang, MD – Sun Yat-Sen University Cancer Center

  • 5:45 PM – 5:50 PM PT
    1180 - Risk-Stratification using the 40-Gene Expression Profile (40-GEP) Test Identifies Patients with Node Negative Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Metastasis Who May Benefit from
    Location: Room 4

    Presenter: Anesh Prasai, PhD – Castle Biosciences, Inc

  • 5:15 PM – 6:15 PM PT
    3213 - Effect of External Beam Radiation Therapy (EBRT) and Brachytherapy (BT) on Circulating MDSC Populations in Patients Treated Definitively for Cervical Cancer
    Location: Hall B1

    Presenter: Kelsey Wanhainen, PhD – University of Minnesota

  • Wednesday, October 4, 2023
  • 8:00 AM – 8:07 AM PT
    264 - Efficacy and Toxicity of Different Target Volume Delineations of Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in Patients with High Grade Glioma: A Randomized, Controlled Clinical T
    Location: Room 33

    Presenter: Feng Liu, MD – Hunan Cancer Hospital

  • 8:10 AM – 8:17 AM PT
    265 - Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide (TMZ) for Recurrent Anaplastic Astrocytoma (AA) and Glioblastoma Multiforme (GBM): A Single-Arm Phase I/II Trial
    Location: Room 33

    Presenter: Timothy Lin, MD, MBA – Johns Hopkins University

  • 8:20 AM – 8:27 AM PT
    266 - Multi-Institutional Report of Re-Irradiation for Recurrent High-Grade Glioma
    Location: Room 33

    Presenter: Hosniya Zarabi, MD, MS, BS – Wake Forest Baptist Medical Center

  • 8:30 AM – 8:37 AM PT
    267 - Oncogenic Activities of Tribbles1 (TRIB1) Pseudokinase Overexpressed in GBM Are Mediated By Protein-Protein Interactions
    Location: Room 33

    Presenter: Karnika Singh, PhD – OSU CCC

  • 8:40 AM – 8:47 AM PT
    268 - A Combined Phase 0/2 "Trigger" Trial of Niraparib in Combination with Radiation in Patients with Newly-Diagnosed Glioblastoma
    Location: Room 33

    Presenter: William Kennedy, MD – Barrow Neurological Institute

  • 8:50 AM – 9:00 AM PT
    Discussant
    Location: Room 33

    Discussant: Jennifer Yu, MD, PhD – Cleveland Clinic Taussig Cancer Center

  • 8:05 AM – 8:10 AM PT
    1206 - Very Low Dose Radiation Therapy for Indolent Lymphomas: Comparing "Big Boom" (4Gy x 1) vs. "Boom Boom" (2Gy x 2)
    Location: Room 8

    Presenter: Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center

  • 8:10 AM – 8:15 AM PT
    1208 - Distribution and Failure Patterns of Primary Central Nervous System Lymphoma Related to Hippocampus
    Location: Room 8

    Presenter: Hye-Jo Ryu, MD – Seoul National University

  • 8:15 AM – 8:20 AM PT
    1210 - Acute Pulmonary Toxicity after Allogeneic Stem Cell Transplantation Using Total Body Irradiation-Based Conditioning- Myeloablative vs. Non-Myeloablative Regimens
    Location: Room 8

    Presenter: Christopher Kelsey, MD, FASTRO – Duke University Medical Center

  • 8:20 AM – 8:25 AM PT
    1212 - Irradiated Extramedullary Acute Myeloid Leukemia Increases Survival in a Leukemic Mouse Model
    Location: Room 8

    Presenter: Francisco Saenz, PhD, MS – University of Texas MD Anderson Cancer Center

  • 8:25 AM – 8:30 AM PT
    1214 - First-in-Human Phase I Trial Combining Biologically Guided Radioimmunotherapy (RIT) Using a 90Y-Anti-CD25 Monoclonal Antibody (Mab) with CT-guided Total Marrow and Lymphoid Irradiation (TML
    Location: Room 8

    Presenter: Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center

  • 8:30 AM – 8:35 AM PT
    1216 - Long-Term Toxicity after Total Body Irradiation-Based Conditioning Regimens for Allogeneic Stem Cell Transplantation
    Location: Room 8

    Presenter: Pranalee Patel, MD, BS – Duke University School of Medicine

  • 8:05 AM – 8:10 AM PT
    1218 - Failure Mode and Effects Analysis for Treatment Workflow of a Novel Ring Gantry Linac
    Location: Room 7

    Presenter: Shada Wadi-Ramahi, PhD – University of Pittsburgh, Hillman Cancer Center

  • 8:10 AM – 8:15 AM PT
    1220 - ACR Accreditation of a Novel Linac-Based kV-CBCT System on a High-Speed Ring-Gantry
    Location: Room 7

    Presenter: Allison Haertter, MS – New York Proton Center

  • 8:15 AM – 8:20 AM PT
    1222 - Dosimetric Comparison of Adaptive Radiotherapy Modalities for Stereotactic Partial Breast Irradiation
    Location: Room 7

    Presenter: Yesenia Gonzalez, PhD – UT Southwestern Medical Center

  • 8:20 AM – 8:25 AM PT
    1224 - Extended Field Radiosurgery of Spinal Metastases with MRI-Guided Adaptive Planning: A Dosimetric Study
    Location: Room 7

    Presenter: Beatriz Guevara, MS – Sylvester Comprehensive Cancer Center

  • 8:25 AM – 8:30 AM PT
    1226 - Predicting Prostate VMAT 3D Radiation Doses of Continuously Varying Organ Dose Trade-Offs Using a Conditional Variational Autoencoder
    Location: Room 7

    Presenter: Simeng Zhu, MD – Ohio State University James Cancer Hospital

  • 8:30 AM – 8:35 AM PT
    1228 - Brachytherapy Dose Prediction Based on Monte Carlo Simulations Using Artificial Neural Networks
    Location: Room 7

    Presenter: Zhen Li, MS – Shanghai Sixth People's Hospital

  • 9:15 AM – 9:45 AM PT
    Discussant
    Location: Ballroom 20

    Discussant: Kimmie Ng, MD, MPH – Dana-Farber Cancer Institute / Harvard Medical School

  • 9:45 AM – 10:15 AM PT
    Discussant
    Location: Ballroom 20

    Discussant: Kristy Brock, PhD, FASTRO – MD Anderson Cancer Center

  • 10:30 AM – 10:37 AM PT
    269 - More Efficient Auto-Segmentation Framework Using Patient-Specific Information for CBCT-Guided Adaptive Radiotherapy
    Location: Room 5

    Presenter: Yuxiang Liu, MS – ASTRO Show Management

  • 10:40 AM – 10:47 AM PT
    270 - New Data-Driven Gated (DDG) PET/CT for Radiation Treatment Planning of NSCLC
    Location: Room 5

    Presenter: Tinsu Pan, PhD – MD Anderson Cancer Center

  • 10:50 AM – 10:57 AM PT
    271 - Failure Mode and Effects Analysis Prior to the Introduction of AI Generated GTVs for Brain Metastases in the Clinical Workflow
    Location: Room 5

    Presenter: Michalis Aristophanous, PhD – Memorial Sloan Kettering Cancer Center

  • 11:00 AM – 11:07 AM PT
    272 - An Automated Brain Metastasis Detection and Segmentation System from MRI with a Large Multi-Institutional Dataset
    Location: Room 5

    Presenter: Youngjin Yoo, PhD – Siemens Healthineers

  • 11:10 AM – 11:17 AM PT
    273 - Clinical Outcomes of Image-Guided Volumetric Modulated Arc Therapy for Total Body Irradiation
    Location: Room 5

    Presenter: Sarah Kilic, MD, MS – Arizona Oncology

  • 11:20 AM – 11:27 AM PT
    274 - Dosimetric and Clinical Results of a Volumetric-Based Skin-Sparing Planning Technique for Patients Treated to the Breast and Chest Wall with Pencil Beam Scanning Proton Therapy
    Location: Room 5

    Presenter: Avani Rao, MD – Radiation Oncology Associates

  • 10:30 AM – 10:37 AM PT
    275 - Patient-Level Savings Using the Mark Cuban Cost Plus Drugs Company for Radiation Oncology Patients
    Location: Room 4

    Presenter: Ramez Kouzy, MD – MD Anderson Cancer Center

  • 10:40 AM – 10:47 AM PT
    276 - Clinical Sequalae of Initial Insurance Denials in a Large Academic Radiation Oncology Center
    Location: Room 4

    Presenter: Jacob Shin, MD – Memorial Sloan Kettering Cancer Center

  • 10:50 AM – 10:57 AM PT
    277 - Association of Managed Medicaid Plans and Cancer Stage at Diagnosis
    Location: Room 4

    Presenter: Justin Barnes, MD, MS – Washington University School of Medicine

  • 11:00 AM – 11:07 AM PT
    278 - Comparing Changes in Medicare Reimbursement for Radiation Oncology and Medical Oncology (2010-2020)
    Location: Room 4

    Presenter: Jacob Hogan, BS – Washington University in St. Louis School of Medicine

  • 11:10 AM – 11:17 AM PT
    279 - Financial Improvements from Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer Compared to Standard of Care, "SAVE" Trial
    Location: Room 4

    Presenter: Cristina DeCesaris, MD – University of Utah Huntsman Cancer Institute

  • 11:20 AM – 11:27 AM PT
    280 - Unplanned Hospitalization and Subsequent Mortality in Lung Cancer Patients Undergoing Concomitant Chemo-/Immuno-Therapy and Radiotherapy: An Analysis of Over 10,000 Patients in a Nationwide Database
    Location: Room 4

    Presenter: Jongmyung Kim, MD, PhD – Rutgers Cancer Institute of New Jersey

  • 10:35 AM – 10:40 AM PT
    1230 - Hybrid Immuno-RT for Bulky Tumors: Standard Fractionation with Partial Tumor SBRT
    Location: Room 8

    Presenter: Ren Luo, MD, PhD – Huaxi Hospital

  • 10:40 AM – 10:45 AM PT
    1232 - Fungal Depletion Bolsters Anti-Tumor Immune Response Elicited by Anti-PD1 Alone and in Combination with Radiation Therapy
    Location: Room 8

    Presenter: Satchel Stevens, BS – Cedars-Sinai Medical Center

  • 10:45 AM – 10:50 AM PT
    1234 - Non-Canonical NF-kB Pathway Suppresses Anti-Tumor Micro-environment and Prompts Pre-Metastasis Niches for Conventional Fractionated Radiotherapy
    Location: Room 8

    Presenter: Dawei Chen, MD, MB

  • 10:50 AM – 10:55 AM PT
    1236 - Irradiated Tumor Cells-derived Exosomes Modulate Macrophage Polarization by Targeting SHP-2 Mediated Metabolic Reprogramming
    Location: Room 8

    Presenter: Dawei Chen, MD, MB

  • 10:55 AM – 11:00 AM PT
    1238 - Radiation Therapy Sensitizes Head-and-Neck Cancer Cells to Killing by Chimeric Antigen Receptor (CAR)-NK Cells Targeting CD70
    Location: Room 8

    Presenter: Gohar Manzar, MD, PhD – MD Anderson Cancer Center

  • 11:00 AM – 11:05 AM PT
    1240 - Malignant Peripheral Nerve Sheath Tumors Activate Distinct Immunosuppressive Pathways Following Radiotherapy and are Associated with Immune Depletion In Vivo
    Location: Room 8

    Presenter: Iowis Zhu, PhD – University of California, San Francisco

  • 10:35 AM – 10:40 AM PT
    1242 - Evaluation of Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilmumab or Nivolumab Alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non
    Location: Room 7

    Presenter: Michael Weisman, MD – IU Health Methodist Hospital

  • 10:40 AM – 10:45 AM PT
    1244 - A Novel FDG PET and Mean Lung Dose Model to Identify Stage III NSCLC Patients at High Risk of Developing Early Radiation Pneumonitis
    Location: Room 7

    Presenter: Maria Thor, PhD, MS – Memorial Sloan Kettering Cancer Center

  • 10:45 AM – 10:50 AM PT
    1246 - Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint
    Location: Room 7

    Presenter: Nikhil Yegya-Raman, MD – University of Pennsylvania Health System

  • 10:50 AM – 10:55 AM PT
    1248 - Investigating Dosimetry and Imaging Biomarkers for Prediction of Major Adverse Cardiac Events Following Locally Advanced Non-Small Cell Lung Cancer Radiotherapy
    Location: Room 7

    Presenter: Hyunsoo No, MD, CMD – Stanford University

  • 10:55 AM – 11:00 AM PT
    1250 - Association of Left Ventricular Myocardium Dose Exposure with Heart Failure in Lung Cancer Radiotherapy
    Location: Room 7

    Presenter: Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center

  • 11:00 AM – 11:05 AM PT
    1252 - Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer - A Secondary Analysis of the LUSTRE Randomized Trial
    Location: Room 7

    Presenter: Che Hsuan David Wu, MD – BC Cancer Agency - Vancouver Island Centre

  • 10:30 AM – 10:37 AM PT
    281 - Health-Related Quality of Life at Five Years for a Randomized Trial of Tri-Modality Therapy with I-125 Brachytherapy, External Beam Radiation Therapy, and Short- vs. Long-Term Androgen Deprivation The
    Location: Room 1

    Presenter: Atsunori Yorozu, MD, PhD – National Hospital Organization Tokyo Medical Center

  • 10:40 AM – 10:47 AM PT
    282 - Patient-Reported Urinary and Bowel Quality of Life Outcomes Following External Beam Radiotherapy with or without High-Dose-Rate Brachytherapy Boost: Post-Hoc Analyses of TROG 03.04 (RADAR)
    Location: Room 1

    Presenter: Wee Loon Ong, MBBS – Alfred Health Radiation Oncology

  • 10:50 AM – 10:57 AM PT
    283 - Conditional Risk and Predictive Factors Associated with Late Toxicity for Prostate Cancer Patients Treated with External Beam Radiotherapy Alone on Randomized Trial RTOG 0126
    Location: Room 1

    Presenter: Gregory Alexander, MD – Thomas Jefferson University

  • 11:00 AM – 11:07 AM PT
    284 - Late Urinary Toxicity and QOL with Curative Radiotherapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase III Trial
    Location: Room 1

    Presenter: Priyamvada Maitre, MD – The Christie NHS Foundation Trust

  • 11:10 AM – 11:17 AM PT
    285 - Toxicity and Patient Reported Quality of Life after PSMA-PET and mpMRT-Based Focal Dose Escalated Definitive Radiotherapy in Prostate Cancer Patients: 2-Year Follow-Up of the HypoFocal Phase II Trial
    Location: Room 1

    Presenter: Simon Spohn, MD – University Medical Center Freiburg

  • 11:20 AM – 11:27 AM PT
    286 - Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy
    Location: Room 1

    Presenter: Abdenour Nabid, MD – CHUS

  • 11:30 AM – 11:40 AM PT
    Discussant
    Location: Room 1

    Presenter: William Jackson, MD – University of Michigan

  • 10:30 AM – 10:37 AM PT
    287 - Treatment Terminations during Radiation Therapy: A Ten-Year Experience
    Location: Room 2

    Presenter: Jason Nosrati, MD – Northwell Health Center for Advanced Medicine

  • 10:40 AM – 10:47 AM PT
    288 - Quantitative and qualitative impact of CT-Based Radiotherapy Dose Maps on Radiologists Interpretation of Post-treatment Thoracic Surveillance Imaging
    Location: Room 2

    Presenter: Kira Newell, BA – University of Washington School of Medicine

  • 10:50 AM – 10:57 AM PT
    289 - Quality Assurance in a Phase III, Multicenter, Randomized Trial of POstmastectomy radioThErapy in Node posiTive Breast Cancer with or without Internal mAmmary nodaL Irradiation (POTENTIAL): A Planning
    Location: Room 2

    Presenter: Yuchun Song, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

  • 11:00 AM – 11:07 AM PT
    290 - Reducing Patient Care Delays in Radiation Oncology via Optimization of Insurance Pre-Authorization
    Location: Room 2

    Presenter: Maxwell Tran, MD – MUSC

  • 11:10 AM – 11:17 AM PT
    291 - Optimization of Workup Pathways to Decrease Radiotherapy Wait Times and Improving Patient Experience: A Single Center Study
    Location: Room 2

    Presenter: Abdulmajeed Dayyat, MD

  • 11:20 AM – 11:27 AM PT
    292 - Can We Improve the Quality of Care Delivered to Cervical Cancer Patients? Development of Quality Metrics and Quality Improvement Program at a Single Institution
    Location: Room 2

    Presenter: Sudha Amarnath, MD – Cleveland Clinic Taussig Cancer Center

  • 11:30 AM – 11:40 AM PT
    Discussant
    Location: Room 2

    Discussant: Manju Sharma, PhD – University of California, San Francisco

  • 12:30 PM – 12:37 PM PT
    293 - Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial
    Location: Room 1

    Presenter: Christophe Le Tourneau, MD, PhD – Institut Curie

  • 12:40 PM – 12:47 PM PT
    294 - Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Locally Advanced Laryngeal/Hypopharyngeal Carcinoma: Preliminary Results of INSIGHT Study
    Location: Room 1

    Presenter: Xiaomin Ou, MD – Fudan University Shanghai Cancer Center

  • 12:50 PM – 12:57 PM PT
    295 - SBRT in 3 Fractions for T1 Glottic Cancer
    Location: Room 1

    Presenter: Giuseppe Sanguineti, MD, Mr – Regina Elena National Cancer Institute

  • 1:00 PM – 1:07 PM PT
    296 - Identifying a Dose Constraint for the Parotid Ducts: Impact on Patient Reported Xerostomia and Comparison to Conventional Parotid Gland Mean Dose Sparing
    Location: Room 1

    Presenter: Shiva Das, PhD – University of North Carolina

  • 1:10 PM – 1:17 PM PT
    297 - Dose Painting Radiotherapy Guided by Diffusion-Weighted Magnetic Resonance vs. 18F-FDG-PET/CT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized, Controlled Clinical Trial
    Location: Room 1

    Presenter: Feng Liu, MD – Hunan Cancer Hospital

  • 1:20 PM – 1:30 PM PT
    Discussant
    Location: Room 1

    Discussant: Michelle Mierzwa, MD – University of Michigan

  • 12:35 PM – 12:40 PM PT
    1254 - Intracranial Control with Combined Dual Immune-Checkpoint Blockade and SRS for Melanoma and NSCLC Brain Metastases
    Location: Room 7

    Presenter: Eugene Vaios, MD, MBA – Duke Cancer Institute

  • 12:40 PM – 12:45 PM PT
    1256 - Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): One-Year Safety and Efficacy Outcomes From a Multicenter Phase I Trial
    Location: Room 7

    Presenter: Shearwood McClelland, MD – University Hospitals Cleveland

  • 12:45 PM – 12:50 PM PT
    1258 - Initial Report of Boswellia Serrata for Management of Cerebral Radiation Necrosis After Stereotactic Radiosurgery for Brain Metastases
    Location: Room 7

    Presenter: Rituraj Upadhyay, MD, MBBS, DNB – Ohio State University

  • 12:50 PM – 12:55 PM PT
    1260 - Frameless LINAC-Based Stereotactic Radiosurgery is Safe and Effective for Essential and Parkinsonian Tremor
    Location: Room 7

    Presenter: Nii-Kwanchie Ankrah, MD – University of Alabama Birmingham Hospital

  • 12:55 PM – 1:00 PM PT
    1264 - Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: A Toxicity Analysis
    Location: Room 7

    Presenter: Jennifer Matsui, PhD – The Ohio State

  • 1:05 PM – 1:10 PM PT
    2236 - Feasibility of Cognitive-Sparing Stereotactic Radiosurgery for Brain Metastases: Initial Report of Phase II COG-SRS Trial
    Location: Room 7

    Presenter: Austin Hopper, MD – UCSD Radiation Medicine and Applied Sciences

  • 12:35 PM – 12:40 PM PT
    1266 - Very APBI in 1 or 2 Days: Late Toxicity and Early Oncological Outcomes of the GEC-ESTRO Cohort
    Location: Room 8

    Presenter: Jean-Michel Hannoun-Levi, MD, PhD

  • 12:40 PM – 12:45 PM PT
    1268 - Proton vs. Photons for Breast Cancer Patients with Immediate, Implant-Based Reconstruction Receiving Postmastectomy Radiotherapy: A Multicenter Pooled Analysis
    Location: Room 8

    Presenter: Myrsini Ioakeim-Ioannidou, MD – Massachusets General Hospital

  • 12:45 PM – 12:50 PM PT
    1270 - A Phase II Randomized Clinical Trial to Assess Toxicity and Quality of Life of Breast Cancer Patients with Hypofractionated vs. Conventional Fractionation Radiotherapy with Regional Nodal Irradiation
    Location: Room 8

    Presenter: Gabriel Gil, MD, PhD, MBA, MS – Rede Mater Dei

  • 12:50 PM – 12:55 PM PT
    1272 - Cardiological Safety of 5-Fraction Whole Breast Irradiation
    Location: Room 8

    Presenter: Lorenzo Livi, MD

  • 12:55 PM – 1:00 PM PT
    1274 - Pattern and Complication of Reconstructed Breast Cancer Patients Who Received Postmastectomy Radiotherapy in the National Health Insurance Service Cohort
    Location: Room 8

    Presenter: Hye-Jo Ryu, MD – Seoul National University

  • 1:00 PM – 1:05 PM PT
    1276 - Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related Lymphedema
    Location: Room 8

    Presenter: Jia-Qi Huang

  • 12:30 PM – 12:37 PM PT
    305 - Risk of Sexual Dysfunction in Men Treated with Pelvic Radiation Therapy for Locally Advanced Rectal Cancer: 20 Years of Experience with 430 Patients
    Location: Room 4

    Presenter: Kush Patel, BA, MBS – Memorial Sloan Kettering Cancer Center

  • 12:40 PM – 12:47 PM PT
    306 - Prognostic Role and Time Varying Failure Hazard of Neoadjuvant Rectal (NAR) Scores in the Stellar Randomized Phase 3 Trial
    Location: Room 4

    Presenter: Yuan Tang, MD – Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College

  • 12:50 PM – 12:57 PM PT
    307 - Relationships between Microbiome and Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
    Location: Room 4

    Presenter: Bum Sup Jang, MD, PhD – Seoul National University Hospital

  • 1:00 PM – 1:07 PM PT
    308 - Long-Term Anorectal Function in Rectal Cancer Patients Managed by a Watch-and-Wait Strategy after Neoadjuvant Therapy: A Cross-Sectional Study
    Location: Room 4

    Presenter: Xin Jin, MD – Fudan University Shanghai Cancer Center

  • 1:10 PM – 1:17 PM PT
    309 - Phase 1 Trial of SPECT-Guided Liver-Directed Ablative Radiotherapy for Patients with Low Functional Liver Volume
    Location: Room 4

    Presenter: Enoch Chang, MD – MD Anderson Cancer Center

  • 1:20 PM – 1:27 PM PT
    310 - Stereotactic Body Radiotherapy Combined with Sintilimab in Patients with Recurrent or Oligometastatic Hepatocellular Carcinoma: A Phase II Clinical Trial
    Location: Room 4

    Presenter: Shisuo Du, MD, PhD – Zhongshan Hospital Fudan University

  • 1:30 PM – 1:45 PM PT
    Discussant
    Location: Room 4

    Discussant: Erqi Pollom, MD, MS – Stanford University

  • 12:50 PM – 12:57 PM PT
    307 - Relationships between Microbiome and Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
    Location: Room 4

    Presenter: Hye In Lee, MD – Seoul National University Hospital

  • 1:30 PM – 1:40 PM PT
    Discussant
    Location: Room 4

    Discussant: Kimberly Johung, MD, PhD – Yale University School of Medicine

  • 12:30 PM – 12:37 PM PT
    311 - Phase II Multi-Institutional Study of a Low-Dose (4Gy) Palliative Response-Adapted Radiotherapy Regimen for Symptomatic Bone Metastases from Multiple Myeloma: Planned Interim Analysis of First 40 Pati
    Location: Room 5

    Presenter: Leslie Ballas, MD – Cedars Sinai

  • 12:40 PM – 12:47 PM PT
    312 - Phase I Study of Bortezomib, Fludarabine, and Melphalan, with or without Total Marrow Irradiation As Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk or R
    Location: Room 5

    Presenter: Colton Ladbury, MD, BS – City of Hope National Medical Center

  • 12:50 PM – 12:57 PM PT
    313 - Predictors of Local Control with Palliative Radiotherapy for Multiple Myeloma
    Location: Room 5

    Presenter: Robert Gao, MD – Mayo Clinic

  • 1:00 PM – 1:07 PM PT
    314 - Phase 2 Trial of Anti-PD1 and 8 Gy in 1 Fraction for Relapse/Refractory Myeloma
    Location: Room 5

    Presenter: Mohammad Khan, MD, PhD – Emory University

  • 1:10 PM – 1:17 PM PT
    315 - Radiation in a New Era of Multiple Myeloma Management: Patterns of Utilization, Clinical, Radiologic, and Biochemical Outcomes, and Possible Genomic Correlates of Response
    Location: Room 5

    Presenter: Alexandra Dreyfuss, MD – Memorial Sloan Kettering Cancer Center

  • 1:20 PM – 1:27 PM PT
    316 - Clinical Outcome and Patterns of Failure in Patients with Solitary Plasmacytoma Treated with Radical Radiotherapy
    Location: Room 5

    Presenter: Ahitagni Biswas, MD, DNB, FRCR – All India Institute of Medical Sciences

  • 1:30 PM – 1:40 PM PT
    Discussant
    Location: Room 5

    Discussant: Youlia Kirova, MD – Institut Curie

  • 12:30 PM – 12:37 PM PT
    298 - Landscape of the Radiosensitizing Properties of Targeted Agents from the NCI CTEP Portfolio across Genomically Diverse 3D Tumor Models
    Location: Room 2

    Presenter: Henning Willers, MD, FASTRO – Massachusetts General Hospital

  • 12:40 PM – 12:47 PM PT
    299 - Intercellular Mechanisms of Therapeutic Resistance at the Tumor-Stromal Interface Using Ultra High-Plex Single-Cell Spatial Transcriptomics and Genetically-Engineered Tumoroids
    Location: Room 2

    Presenter: Ryan Zhao, MD

  • 12:50 PM – 12:57 PM PT
    300 - Coupling In Vivo CRISPR Perturbation with Single Cell Transcriptomics Defines Gene-Treatment Interactions and Reveals the Role of DNA-PK as a Targetable Radiation Vulnerability in Glioblastom
    Location: Room 2

    Presenter: S. John Liu, MD, PhD – UCSF

  • 1:00 PM – 1:07 PM PT
    301 - Genetically Engineered Mouse Models of CIC-DUX4 Sarcoma Reveal an Unexpected Sensitivity to Histone Deacetylase (HDAC) Inhibition
    Location: Room 2

    Presenter: Peter Hendrickson, MD, PhD – Duke University School of Medicine

  • 1:10 PM – 1:17 PM PT
    302 - Enhancing Immune-Mediated Radiotherapy Efficacy in Murine Models of Head and Neck Cancer through Peroxisome Proliferator-Activated Receptor Modulation
    Location: Room 2

    Presenter: Richard Ross, MD – University of Colorado Anschutz Medical Campus

  • 1:20 PM – 1:27 PM PT
    303 - Gamma Secretase Inhibition Sensitizes Pancreatic Adenocarcinoma Tumors to RT In Vivo
    Location: Room 2

    Presenter: Adam Mueller, MD, PhD – Thomas Jefferson University

  • 1:30 PM – 1:37 PM PT
    304 - Listeriolysin O Drives Innate and Adaptive Immune Responses to CD47 Immunotherapy
    Location: Room 2

    Presenter: Benjamin Schrank, MD, PhD – MD Anderson Cancer Center

  • Sunday, September 29, 2024
  • 8:00 AM – 8:10 AM PT
    Quick Pitch Session - Abstract Presenter Reg Test

    Presenter: MIT TEST, BS – TEST Company

  • 8:00 AM – 8:10 AM PT
    Scientific Session - Abstract Presenter Reg Test

    Presenter: Resident Fellow Test, DO – Test Company 3

  • 9:30 AM – 9:40 AM PT
    Clinical Trials Session - Abstract Presenter Test Abstract

    Presenter: Bandana TEST, MD – TEST Company

  • Monday, September 30, 2024
  • 1:30 PM – 1:40 PM PT
    Plenary Session - Abstract Presenter Reg Test

    Presenter: Medical Director TEST, BS – TEST Company 2

  • Wednesday, October 2, 2024
  • 6:00 AM – 7:00 AM PT
    TEST 022324

    Presenter: Onon Ichinkhorloo, MSM – American Society for Radiation Oncology

  • 6:00 AM – 7:00 AM PT
    TEST 022324

    Presenter: International TEST, PhD – TEST International Company